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Abstract 
 
Manufactured nanomaterials have been of extreme importance due to the beneficial 
physicochemical properties they possess compared to bulk parental materials. However, 
the properties that make them so attractive are also the same that can cause harm both to 
humans and environment.  Over the last years there has been a rapid development of the 
nanotechnology industry and the inevitable human exposure tends rapidly to expand, 
accompanied by potential for adverse health effects. 
Among all used nanoparticles (NPs), silver nanoparticles (AgNPs) have the highest 
level of commercialization. Silver has been used for decades in medical healthcare due 
to its known antibacterial properties. One can also observe AgNPs in products used 
daily such as cosmetics, lotions, toothpastes, soaps, sunscreen, clothing and electronics. 
Over the last years, nanoparticles have been the subject of intense research for use in 
biomedicine, namely as biosensors, drug-delivery agents and imaging contrast agents, 
which take advantage of their unique optical properties. 
Human exposure to AgNPs can occur through different ways: inhalation, ingestion, 
injection and dermal contact. As a major organ of detoxification, the liver is one of the 
most important targets after AgNPs exposure. The main toxicological concern is the fact 
that AgNPs preferentially accumulate in mitochondria. Since mitochondria have an 
essential bioenergetic function, impairment of mitochondria by nanoparticles may have 
drastic consequences on cellular function. 
The mechanism by which AgNPs cause toxicity is still subject to uncertainty. 
However, oxidative stress has been related with the AgNPs toxicity. Therefore, 
antioxidant therapy might be a viable strategy for attenuating this toxicity. 
In this work, we evaluated the toxicity of silver nanoparticles (10- and 75 nm) and 
their effects in rat liver mitochondrial bioenergetics. In vivo exposure to AgNPs was 
capable of increasing plasmatic aspartate aminotransferase (AST) and lactate 
dehydrogenase (LDH) activities, suggesting hepatocellular injury. Mitochondria 
isolated from animals treated with both AgNPs sizes showed a significant increase on 
reactive oxygen species (ROS) generation. Moreover, AgNPs caused impairment of rat 
liver mitochondrial function, mainly due to alterations of mitochondrial membrane 
permeability leading to an uncoupling effect on the oxidative phosphorylation system. 
AgNPs also compromised the electron transfer along the electron transport chain by 
vi 
 
affecting the activity of complexes II and IV of the respiratory chain and interfered with 
the mitochondrial permeability transition (MPT) induction. 
We found that most of the effects caused by AgNPs exposure were prevented by 
pretreatment with N-acetylcysteine (NAC). This antioxidant agent efficiently prevented 
the structural damage in the inner mitochondrial membrane as well as damage to 
mitochondrial electron transport chain complexes. Oxidative phosphorylation and 
calcium retention capacities of hepatic mitochondria were also improved by NAC 
treatment. The preventive effect of NAC efficiency was higher in 75 nm- than 10 nm-
AgNPs, suggesting that smaller NPs have higher cytotoxicity than larger NPs. 
In summary, our results indicate that the liver is a target of AgNPs exposure leading 
to alteration in hepatic mitochondria functions. Thus, the mitochondrial toxicity may 
have a central role in the toxicity resulting from exposure to silver nanoparticles. The 
efficiency of NAC administration against AgNPs toxicity suggests that ROS are 
involved in the mitochondrial toxicity caused by AgNPs treatment.  
 
 
Keywords:  
Mitochondria 
Silver nanoparticles 
Hepatic toxicity 
N-acetylcysteine   
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Resumo 
 
Os nanomateriais manufacturados têm sido de extrema importância devido às 
características físico-químicas benéficas que possuem comparados com os mesmos 
materiais de maiores dimensões. Contudo, as propriedades que os tornam tão atraentes 
são as mesmas que podem causar dano ao ser humano e ao meio ambiente. Ao longo 
dos últimos anos tem-se assistido a um rápido desenvolvimento da indústria de 
nanotecnologia, e a inevitável exposição humana tende a aumentar rapidamente, 
acompanhada por potenciais efeitos adversos para a saúde. 
Das diversas nanoparticulas utilizadas (NPs), as nanoparticulas de prata (AgNPs) 
têm o maior grau de comercialização. A prata tem sido utilizada ao longo de décadas em 
cuidados de saúde devido as suas propriedades antibacterianas. Podemos também 
observar a presença de AgNPs em produtos utilizados no quotidiano tais como, 
cosméticos, loções, pasta dentífrica, sabonetes, protector solar, vestuário e 
electrodomésticos. 
Ao longo dos últimos anos, as nanopartículas têm sido objecto de intensa pesquisa 
para aplicação em biomedicina, nomeadamente como biosensores, agentes de entrega de 
fármacos e agentes de contraste de imagem, tirando partido das suas propriedades 
ópticas únicas.  
A exposição humana a AgNPs pode acorrer de várias formas: inalação, ingestão, 
injeção ou via transdérmica. Como principal órgão de desintoxicação, o fígado é um dos 
alvos mais importantes após a exposição a AgNPs. A principal preocupação 
toxicológica é o facto de as AgNPs se acumularem preferencialmente nas mitocôndrias. 
Uma vez que as mitocôndrias possuem uma função bioenergética essencial, danos nas 
mitocôndrias causados pelas nanoparticulas podem acarretar consequências drásticas na 
função celular. 
O mecanismo através do qual as AgNPs causam toxicidade é ainda incerto. No 
entanto, o stress oxidativo tem sido associado à toxicidade provocada pelas AgNPs. 
Desta forma, a terapêutica antioxidante pode revelar-se uma estratégia viável para 
atenuar essa toxicidade. 
Neste trabalho avaliámos a toxicidade de nanopartículas de prata (10 e 75 nm) e os 
seus efeitos na bioenergética mitocondrial do fígado de rato. Exposição in vivo a AgNPs 
revelou-se capaz de aumentar as actividades plasmáticas da aspartato aminotransferase 
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(AST) e da lactato desidrogenase (LDH), sugerindo dano hepatocelular. Mitocôndrias 
isoladas de fígado de animais tratados com AgNPs de ambos os tamanhos 
demonstraram um aumento significativo na geração de espécies reactivas de oxigénio 
(ROS). Além disso, as AgNPs causaram danos na função mitocondrial principalmente 
devido a alterações na permeabilidade da membrana, provocando um efeito 
desacoplador no sistema de fosforilação oxidativa. 
As AgNPs comprometem também a transferência de eletrões ao longo da cadeia 
transportadora devido ao facto de afetarem as atividades dos complexos II e IV da 
cadeia respiratória e interferirem também com a indução da transição de permeabilidade 
mitocondrial (MPT). 
Demonstramos que a maioria dos efeitos causados pela exposição as AgNPs podem 
foram prevenidos pelo pré-tratamento com N-acetilcisteína (NAC). Este agente 
antioxidante impediu eficientemente a grande maioria dos efeitos das AgNPs nas 
mitocôndrias hepáticas. A fosforilação oxidativa e a capacidade de retenção de cálcio 
das mitocôndrias hepáticas foram também melhoradas através do tratamento com NAC. 
O efeito preventivo do NAC foi maior nas AgNPs de 75 nm do que nas de 10nm, 
sugerindo que NPs mais pequenas apresentam maior citotoxicidade quando comparadas 
com NPs de maiores dimensões.  
Em suma, os nossos resultados demonstram que o fígado é um alvo da exposição a 
AgNPs conduzindo a alterações na função das mitocôndrias hepáticas. Desta forma, a 
toxicidade mitocondrial pode desempenhar um papel fulcral na toxicidade resultante da 
exposição a nanopartículas de prata. A eficácia da administração do NAC contra a 
toxicidade das AgNPs sugere que os ROS estão envolvidos na toxicidade mitocondrial 
provocada pela exposição às AgNPs. 
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Over the last decades there has been a rapid development of the nanotechnology 
industry. It has promised great benefits both economic and scientific that will have 
application in areas as distinct as aerospace engineering, electronics, environmental 
remediation and medical healthcare. Manufactured nanomaterials have been of extreme 
importance to the industry due to the particular physicochemical features they possess 
compared to bulk parental materials. The most important of them comprise improved 
thermal and/or electrical conductivity, harder and stronger materials, improved catalytic 
activity and advanced optical properties (N. Singh et al., 2009). As we discover new 
uses for nanomaterials, the number of products containing them and their application 
will continue to grow exponentially. Thereby nanomaterials released from industrial 
activities and consumer products to the environment will increase and may accumulate 
in plants and animals. The bioaccumulation and propagation of nanomaterials through 
food chains is one of the biggest concerns in nanotoxicology (Bartłomiejczyk et al., 
2013). 
Nanomaterials range in size from 1 to 100 nm and they can take many different 
forms such as tubes, rods, wires or spheres. These nanomaterials can also have different 
dimensions. Thin films and engineered surfaces are examples of one-dimensional 
nanomaterials. On the other hand, there are nanomaterials in two dimensions for 
instance, carbon nanotubes, inorganic nanotubes, nanowires and biopolymers and 
nanomaterials in three dimensions such as nanoparticles, fullerenes (C60), dendrimers 
and quatum dots (The Royal Society and The Royal Academy of Engineering 2004). 
 
 
1.1. Silver Nanoparticles 
Among all used nanoparticles (NPs), silver nanoparticles (AgNPs) have the highest 
level of commercialization (Figure 1.1) (Ahamed et al., 2010). AgNPs are often 
synthesized by a chemical reduction of a silver salt (AgNO3) dissolved in water with a 
reducing compound such as sodium borohydride (NaBH4), citrate, glucose, hydrazine 
and ascorbate (Marambio-Jones & Hoek, 2010; Tolaymat et al., 2010).  
Silver has been used for decades in medical healthcare due to its known 
antibacterial properties (Carlson et al., 2008; Costa et al., 2010; Tolaymat et al., 2010). 
Thereby, AgNPs are widely used in medical devices such as wound dressings, medical 
catheters, contraceptive devices, bone prostheses and surgical instruments (Tolaymat et 
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al., 2010). One can also observe AgNPs in products used daily, for instance cosmetics, 
lotions, creams, toothpastes, soaps, sunscreen, clothing and electronics (Teodoro et al., 
2011; Tolaymat et al., 2010).  
 
 
 
 
 
 
 
  
 
Figure 1.1- Transmission electron microscopy (TEM) image of silver nanoparticles with diameters 
of 10 nm and 75 nm, respectively.  
 
 
The examples shown so far are related with unintentional exposure to NPs. 
However, there are some cases where exposure is made on purpose such as applications 
of NPs as biosensors, drug-delivery agents and imaging contrast agents (R. Zhang et al., 
2012) as well as treatments of diseases that require constant drug concentration in the 
blood or targeting of specific cells (Ahamed et al., 2008). For instance, Elechiguerra and 
colleagues have shown that AgNPs undergo size-dependent interactions with the HIV-1 
virus and inhibit its binding to the host cell in vitro (Elechiguerra et al., 2005).  
As mentioned above, NPs have physicochemical properties that make them so 
useful and provide them advantages upon the bulk materials. The most important ones 
are the size, shape, crystallinity, surface charge and coating, elemental composition and 
solubility (Carlson et al., 2008). Nevertheless, the properties that make NPs attractive 
are also the same properties that can cause danger both to humans and environment 
(Carlson et al., 2008; Teodoro et al., 2011). Although some studies have reported these 
dangers, there is a serious lack of information about the role of NPs in biological 
systems. The studies made so far are scarce and sometimes conflicting, thus it is 
essential understand NPs toxicity, distribution, bioaccumulation as well as its excretion. 
There are several factors that can influence stability and bioavailability of NPs such 
as particle size, shape, capping agents, pH, ionic strength, specific ions and ligands 
Chapter I  General introduction 
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(Marambio-Jones & Hoek, 2010). For instance, high salt levels and pH values close to 
the isoelectric point will enhance agglomeration, resulting in a larger hydrodynamic size 
(Jiang et al., 2008).  
Once inside the cell, NPs can get metabolized and potential physicochemical 
changes can occur (Teodoro et al., 2011), especially hydrodynamic size and surface 
charge (Jiang et al., 2008) causing unpredictable behavior. Thus it is essential the 
characterization of these nanoparticles in solution.  
 
 
1.1.1. Size 
The nanometric size is one of the main features that provide NPs unique properties 
when compared with larger materials of the same composition. Their small size allows 
them to easily cross biological barriers and once inside the cell NPs can pass through 
membranes into critical organelles such as mitochondria and interact with biomolecules, 
which can be harmful to normal cellular functioning (Carlson et al., 2008; N. Singh et 
al., 2009). However, this ability to easily cross biological barriers could be 
advantageous when NPs are used on development of new nanomedicines and 
nanodevices for clinical healthcare. 
All NPs, regardless of their chemical composition, have surface area:volume ratios 
that are extremely high (Table I). As the size decreases, the number of particles per unit 
of mass increases as well as its surface area. This larger surface area:volume ratios 
enhances the catalytic activity of the material and thus increases its reactivity with other 
molecules (N. Singh et al., 2009). Hence, it is suggested that size is one of the main 
characteristics responsible for cytotoxicity of AgNPs. Several studies have reported that 
smaller AgNPs induced more cytotoxicity than larger AgNPs (Ahamed et al., 2008; 
Carlson et al., 2008; Monteiller et al., 2007) 
Smaller AgNPs can pass through cell membranes more efficiently than larger 
AgNPs and due to their smaller size they have a larger surface area available for 
interaction with cellular organelles. Moreover, the higher surface area allows smaller 
AgNPs to enhance release of Ag
+
 ions from their surface (Kim & Ryu, 2013). AgNPs 
release Ag
+ 
in the presence of water (Kim & Ryu, 2013; Lee et al., 2013; Tiwari et al., 
2011) probably due to surface oxidation and this release of Ag
+ 
ions might lead to an 
amplification of AgNPs toxicity (R. Zhang et al., 2012).  
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Table I - Diameter, Surface area and Volume of nanosphere (Source: www.nanocomposic.com) 
 
 
1.1.2. Shape 
With regards to shape, there are some reports showing different rates of uptake 
depending on the type of nanoparticles shape. For instance, spherical nanoparticles have 
shown higher uptake than nanorods (N. Singh et al., 2009). 
Many nanomaterials have an inherent property, their hydrophobicity and as result a 
likelihood to agglomerate/aggregate mainly under physiological conditions (Kim & 
Ryu, 2013; N. Singh et al., 2009). Therefore when NPs are in a biological system, it is 
likely that it will be in the form of aggregates rather than individual units. Thus, in such 
conditions NPs might no-longer be in nano size range. Thus, their effects upon 
biological systems may be considerably lower probably due to reduced cellular uptake 
or an inability to cross biological barriers (N. Singh et al., 2009). This problem of 
aggregation can be overcome modifying the surface of nanomaterials with capping 
agents. A capping agent is used to promote stability of NPs, resulting in a surface 
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polarity that prevents aggregation of nanoparticles due to electrostatic repulsion (El 
Badawy et al., 2010). Sodium citrate is the most common capping agent used (Tolaymat 
et al., 2010). Citrate-capped AgNPs have negative surface charge due to the carboxylic 
moiety of the citrate and this negative charge increases the repulsion between NPs and 
prevents aggregation (Figure 1.2) (Park & Lee, 2013). Thus the cellular uptake 
increases, overloading the cellular systems with nanoparticles. Murdock et al., (2008) 
reported uncoated particles tend to agglomerate while coated are far more dispersed. 
Ahamed and colleagues showed differences between coated and uncoated NPs, 
demonstrating that coated AgNPs cause more severe problems than uncoated AgNPs 
(Ahamed et al., 2008).  
 
 
 
 
 
 
Figure 1.2- Schematic representation of citrate-capped AgNPs. Citrate has negative charge due to the 
carboxylic moiety giving to citrate-capped AgNPs negative surface charge. This negative surface charge 
increases the repulsion between NPs preventing aggregation (adapted from Zheng, Yu, Xu, & Chen, 
2014). 
 
 
1.1.3. Uptake 
The uptake of NPs by cells depends on the size and shape of the particles, the 
surface charge, and the surface functionalization of the particles. Smaller NPs are 
internalized more efficiently compared to larger NPs. 
Surface charge influences cellular uptake of nanomaterials because once the plasma 
membrane is negatively charged, nanomaterials with cationic surface charges 
(positively charged) may interact more efficiently with plasma membrane than those 
that are anionic (negatively charged) (N. Singh et al., 2009). Regarding to surface of 
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NPs, the surface chemistry can be altered by attachment of biomolecules for cell 
targeting or drug delivery. 
In mammalian cells, NPs undergo uptake by mechanisms as phagocytosis, 
macropinocytosis, caveolae-dependent endocytosis, nonclathrin-, non-caveolae-
mediated endocytosis, clathrin-dependent endocytosis, phagocytosis, and diffusion 
(Figure 1.3) (Asharani et al., 2009; Unfried et al., 2007). Regarding to AgNPs, clathrin-
dependent endocytosis and macropinocytosis have been shown to be the primary uptake 
mechanism on in vitro studies (Asharani et al., 2009; Greulich et al., 2011).  Using 
animal studies, Lee et al., (2013) shown that AgNPs were localized mainly in 
endosomes and lysosomes of hepatocytes. Therefore, these findings provide evidence 
regarding to previous in vitro reports describing the uptake of AgNPs occur mainly 
through endocytosis. 
 
 
 
 
 
 
 
 
 
Figure 1.3 - Possible pathways of cellular uptake of nanoparticles in mammalian cells. 1- 
phagocytosis; 2-macropinocytosis; 3-clathrin-dependent endocytosis; 4- nonclathrin-, non-caveolae-
mediated endocytosis; 5- caveolae- dependent endocytosis; 6-diffusion. (Unfried et al., 2007) 
 
 
1.1.4. Human exposure 
AgNPs are the focus of this report. Their widespread use and commercialization 
have raised concerns about human and environmental exposure. In humans, argyria, a 
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disease caused by exposure to high levels of silver, produces a benign bluish-gray 
discoloration of the skin and other organs (Carlson et al., 2008). 
Human exposure to AgNPs can occur through different ways: inhalation, ingestion, 
injection and dermal contact (Ahamed et al., 2010; Lee et al., 2013). Once inside the 
body, AgNPs rapidly enter circulation and may migrate to liver, kidney, spleen, lungs 
and brain, inducing toxicity (Figure 1.4) (Aillon et al., 2009; Greulich et al., 2011; 
Singh & Ramarao, 2012). Liver and spleen have been identified as the main target 
organs for nanomaterials after injection. Liver, as a major organ of detoxification, might 
retain nanoparticles due to the presence of specific subpopulations of mononuclear 
phagocytic cells which are part of the reticulo-endothelial  system (RES) 
(Dziendzikowska et al., 2012).  
Important elements of RES are the Kupffer cells that play a crucial role in the 
removal of nanoparticles from the organism (Sadauskas et al., 2007). Lee and 
colleagues observed that AgNPs deposited in Kupffer cells after treatment (Lee et al., 
2013). Excessive accumulation of AgNPs in the liver can lead to certain adverse effects 
such as pathological changes in liver morphology, generation of reactive oxygen species 
(ROS), DNA damage and changes in liver enzyme activities (Tiwari et al., 2011). 
 
 
 
 
 
 
 
 
 
 
Figure 1.4- Main forms of in vivo silver nanoparticles. Once inside the body, silver nanoparticles may 
migrate to liver, kidney, spleen, lungs and brain, inducing toxicity (adapted from Aillon et al., 2009). 
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1.1.5. Mechanisms of toxicity 
The mechanism by which AgNPs cause toxicity is still subject to uncertainty. Some 
researchers suggested that AgNPs might act as a “Trojan horse”, crossing biological 
barriers and then releasing Ag
+
 ions that are the main cause for cell damage. 
Alternatively, some studies suggested that both AgNPs as well as Ag
+
 ions are 
responsible for AgNPs toxicity (Ahamed et al., 2010). Thus, it is important understand 
whether Ag
+
 ions are the only cause of the toxicity of AgNPs or if NPs have also 
toxicity distinct from that of ionic silver. 
 
 
1.1.6. ROS production 
Silver, a soft metal, displays a strong affinity for thiol (–SH) groups present in 
biomolecules found throughout the body, as for example protective antioxidant agents. 
Thus, it is possible that AgNPs might cause an imbalance on human health due to an 
increase of oxidative stress. Metals can act as catalysts and generate ROS in the 
presence of dissolved oxygen. Therefore, this could be a mechanism by which silver 
nanoparticles increase oxidative stress. Both in vitro and in vivo studies have shown that 
AgNPs lead to ROS production (Arora et al., 2008; Carlson et al., 2008; Ghosh et al., 
2012; Tiwari et al., 2011) and thereby these studies are in agreement with the previous 
hypothesis that oxidative stress is one of the main mechanisms which NPs exert their 
toxicity (Monteiller et al., 2007). Arora et al., (2008) found that exposure to AgNPs 
caused depletion of glutathione (GSH) and increased lipid peroxidation, clear signals of 
oxidative stress. Moreover, Hussain et al., (2005) showed a significant increase in ROS 
on BRL 3A liver cells following AgNPs treatment. 
ROS are a general term used to describe molecules and free radicals derived from 
molecular oxygen: singlet oxygen molecules (O), superoxide anions (O2
•-
), hydrogen 
peroxide (H2O2) and the most potent oxidizing agents, hydroxyl radicals (OH
•
).  
Therefore, ROS are produced as byproducts of cellular oxygen metabolism. The 
majority of oxygen consumption in the cell occurs through oxidative phosphorylation, 
and as such mitochondria are the primary source of ROS in the cell.  
Under environmental stress, the cell ROS generation increases, which in turn leads 
to an imbalance between ROS generation and their elimination by antioxidant agents. 
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This imbalance of the redox equilibrium is called oxidative stress and may cause 
transient or even permanent damage to proteins, lipids and nucleic acids, and these 
cumulative alterations can eventually kill the cell by apoptosis or necrosis. 
Eukaryotic organisms have developed a variety of enzymatic and nonenzymatic 
systems to eliminate ROS and try to repair their effects. The most important ones are 
superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione S-
transferase (GST), peroxiredoxins, glutathione (GSH) and vitamins. Among all of these 
antioxidant scavengers, GSH plays a major role in cellular protection against oxidative 
stress due to its ability to bind and reduce ROS (Kim & Ryu, 2013). 
ROS play important roles in normal biochemical functions in the cells such as cell 
signaling and abnormality in ROS metabolism results in pathological processes. For 
example, it is known that excessive production of ROS can induce apoptosis 
(Martindale & Holbrook, 2002). Several studies have shown that ROS production leads 
to apoptotic processes followed by AgNPs treatment (Ahamed et al., 2010; Carlson et 
al., 2008). 
N-acetylcysteine (NAC) is a precursor of the synthesis of GSH and thus is an 
important antioxidativo compound. In vitro studies found that pretreatment with NAC 
prevented AgNPs toxicity in human liver cells and HepG2 (Jing et al., 2011; Kim et al., 
2009), suggesting that the main mechanism of AgNPs toxicity is associated with 
oxidative damage-dependent pathways. 
 
 
1.1.7. Apoptosis 
Apoptosis is a form of programmed cell death, where occurs a shutdown of 
metabolism and digestion of cell contents. Apoptosis takes place when the damage in 
cells, especially that affecting DNA, is beyond repair and cells activate enzymes that 
degrade their own DNA (Kim & Ryu, 2013). The machinery of apoptosis is composed 
of caspases, caspase activators, B-cell lymphoma 2 (Bcl-2) family of proteins and 
inhibitor of apoptosis proteins (IAPs) (Bernardi et al., 1999). Caspases are cysteine 
proteases that play a key role in the apoptotic cascade and the proteolytic digestion of 
the cell. Caspases exist as inactive precursor procaspases and are activated by controlled 
proteolytic cleavage. The Bcl-2 family of proteins is a group of mitochondrial proteins 
that participate in the modulation of the apoptotic phenomenon. This family includes 
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both pro- and anti-apoptotic members that largely localize to the outer mitochondrial 
membrane. The pro-apoptotic BH3-only family members (Bid, Bad, Bim, Noxa and 
Puma) activate the pro-apoptotic proteins Bax and Bak while anti-apoptotic (Bcl-2, Bcl-
xl, Blc-w and Mcl-1) members tend to inhibit them. The balance between pro-apoptotic 
and anti-apoptotic protein levels is crucial for the cell’s fate (Bernardi et al., 1999).   
 
 
1.1.8. Inflammation 
Besides activation of apoptosis, oxidative stress may also activate specific signaling 
pathways such as mitogen activated protein kinase (MAPK) and release of pro-
inflammatory cytokines (Bartłomiejczyk et al., 2013). The activation of these signaling 
cascades causes inflammation which in turn leads to further ROS generation from 
inflammatory cells, resulting in a vicious cycle (N. Singh et al., 2009). It was shown 
that AgNPs increase the secretion of inflammatory cytokines in macrophages cell lines 
(Carlson et al., 2008). The c-Jun-N-terminal kinase (JNK) is a member of the MAPK 
family and plays a proapoptotic function in response to oxidative stress leading to 
apoptosis (Hsin et al., 2008).  
Some studies reported that DNA damage could occur after AgNPs treatment. Arora 
et al., (2009) demonstrated that AgNPs could cause DNA damage in fibroblast and liver 
cells and Ahamed et al., (2008) also found DNA damage after AgNPs exposure. 
The increase of oxidative stress and inflammatory responses may cause DNA 
damage (N. Singh et al., 2009), leading to the activation of p53. The p53 protein is a 
tumor suppressor gene and when DNA is damaged, p53 is able to activate cell cycle 
checkpoints and the transcription of genes responsible for DNA repair, in an attempt to 
avoid the propagation of damage. However, if the damage is too extensive to be 
repaired, p53 induces activation of proapoptotic factors such as Bcl 2-associated X 
protein (BAX), triggering apoptosis to eliminate the individual cell for the benefit of the 
organ. Thus the activation of p53 can be a good marker for assessing NPs genotoxicity. 
In vitro studies shown activation of p53 after AgNPs administration (Ahamed et al., 
2008; Hsin et al., 2008). 
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1.2 Mitochondria 
Mitochondria are the only organelles that contain extra-nuclear DNA and have a 
replication system independent from nuclear DNA replication. Human mitochondrial 
DNA (mtDNA) is a 16 600 base pairs circular, double-stranded molecule, encoding 11 
mRNAs that give rise to 13 subunits of the oxidative phosphorylation system, 22 
transfer RNAs (tRNAs) and two ribosomal RNAs (rRNAs). However, most of the 
mitochondrial proteins are nuclear-encoded and imported into the mitochondria 
(Lagouge & Larsson, 2013). 
Mutations in genes encoding mitochondrial components cause mitochondrial 
dysfunction. This mitochondrial dysfunction has been related with the development of 
metabolic disorders like insulin resistance and diabetes, aging process as well as 
cardiovascular and neurodegenerative diseases (Rolo & Palmeira, 2006; Santos et al., 
2013; Shoubridge, 2001). 
Mitochondria are the powerhouses of the cells since they produce more 95% of 
cell’s total energy requirement (Costa et al., 2010). Thus mitochondria are essential 
organelles for cell survival and growth. The number of mitochondria present in each cell 
depends upon their metabolic requirements and may range from hundreds to thousands. 
Unlike what was thought to a few years ago, mitochondria are dynamic organelles since 
they continuously change their shape and numbers through frequent fusion, fission and 
movement throughout the cell (McBride et al., 2006), processes that are intimately 
linked to the cell’s energetic needs. 
The most well known function of mitochondria involves the production of chemical 
energy through the electron transport chain (ETC). However, besides energy 
production, mitochondria assume other functions such as heme synthesis, β-oxidation of 
free fatty acids, metabolism of certain amino acids, formation and export of Fe/S 
clusters, iron metabolism, and play also a crucial role in calcium homeostasis and cell 
death (Michel et al., 2012).  
 
 
1.2.1 Mitochondrial Structure 
A double phospholipid membrane limits the structure of the mitochondria, the outer 
and inner membrane (Figure 1.5). The outer membrane separates the mitochondrion 
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from the cytosol and encompasses the whole organelle. It main protein is the voltage-
dependent anion channel (VDAC), responsible for the passage of low molecular-weight 
molecules between the cytoplasm and the intermembrane space. The intermembrane 
space is an important compartment on mitochondria, since it acts as a reservoir of 
protons (H
+
) establishing a H
+ 
electrochemical gradient (with electric and pH 
components) across inner membrane that is essential for the production of ATP via ATP 
synthase. Most of this gradient is in form of electrical potential difference. 
The inner membrane forms invaginations towards the internal matrix, designated by 
cristae, increasing the surface area of this membrane. Unlike the outer membrane, the 
inner membrane is largely impermeable to most ions and polar molecules, including 
protons. For that reason, solutes can only cross it through highly regulated and selective 
channels. The inner membrane houses the respiratory enzymes of the ETC and many 
mitochondrial carriers. Within the matrix, different metabolic pathways take place 
including tricarboxylic acid (TCA) or Krebs cycle that generate reducing equivalents 
such as nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide 
(FADH2) which then donate electrons to the ECT and β-oxidation breaks down fatty 
acid molecules to generate Acetyl-Coenzyme A (Acetyl-CoA) which enters the Krebs 
cycle. 
 
 
 
 
 
 
 
 
Figure 1.5- Mitochondrial morphology. Mitochondria are a double membrane-system: the outer 
membrane separates the mitochondrion from the cytosol and defines the outer perimeter and the inner 
membrane, that is invaginated, forms the cristae and defines the matrix of the organelle. 
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1.2.2 Electron Transport Chain 
Four enzymatic protein complexes, complexes I-IV, comprise the ETC. Electrons 
deriving from oxidation of substrates pass through the redox carriers until finally reduce 
molecular oxygen to form water. This electronic transport allows for the vectorial 
ejection of protons across the inner mitochondrial membrane, from the matrix towards 
the intermembrane space. This creates an electrochemical protonic gradient which can 
be used by Complex V, or ATP synthase, to drive the phosphorylation of adenosine 
diphosphate (ADP).  These processes involve the coupling of both redox and 
phosphorylation reactions in the inner membrane of mitochondria, resulting in an 
effective ATP synthesis. To this it is called oxidative phosphorylation (OXPHOS). 
NADH-ubiquinones oxidoreductase (Complex I) accepts electrons from nutrients 
via reduced form of NADH, which then are transported to oxidized ubiquinone (a 
mobile intramembrane protein), originating its reduced form, ubiquinol. Ubiquinone can 
also accept electrons from the reduced form of FADH2, originated from succinate, at 
succinate-ubiquinone oxidoreductase (Complex II). Ubiquinol, a highly mobile protein, 
will then transfer electrons to ubiquinone-cytochrome c oxidoreductase (Complex III) 
and from here to cytochrome c, another mobile protein from the intermembrane space, 
which will reduce cytochrome c oxidase (Complex IV). Here, the electrons are 
transferred to the final electron acceptor, molecular oxygen (O2), generating H2O. It is 
important to notice that this electronic transport is only possible due to the increasingly 
energetic favorable electronic jumps between proteic complexes. The released energy 
from these electronic jumps is used by Complexes I, III and IV to drive the protonic 
ejection against its concentration gradient.  
As mentioned, the consequent movement of the H
+
 creates an electrochemical 
gradient due to the low protonic conductance of the inner mitochondrial membrane. 
This electrochemical gradient consists of a pH gradient (ΔpH) and an electrical gradient 
that are used to drive the synthesis of ATP from ADP as the protons re-flow through the 
ATP synthase proton channel (complex V) (Figure 1.6). After ATP synthesis the 
adenine nucleotide translocase (ANT) allows the exchange of ATP from mitochondrial 
matrix with ADP from cytosol. 
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Figure 1.6- Schematic representation of electron transport chain (ETC). ETC is composed of 
approximately 100 proteins, 13 of which are encoded by the mtDNA. It consists of five protein 
complexes; complex I and complex II receive electrons (e
-
) from intermediary metabolism, which are 
then transferred to coenzyme Q and subsequently delivered to complex III. Cytochrome c then transfers 
the e
-
 to complex IV, which constitutes the final step in the ETC in which molecular oxygen is reduced to 
water. The electron transport is coupled to proton (H
+
) pumping across the inner membrane by complexes 
I, III and IV. The resulting proton gradient drives ATP synthesis through complex V (ATP synthase). C, 
cytochrome c; Q, coenzyme Q. (Image based on Perier & Vila, (2012)) 
 
 
OXPHOS is known as the prime location for ROS generation and thus, 
mitochondria are the first targets of oxidative damage. The generation of mitochondrial 
ROS is a normal consequence of OXPHOS because along the ETC electrons may 
escape and react with O2 generating free radicals. 
Complexes I and III are considered to be the main sites for ROS production in 
mitochondria (Rigoulet et al., 2011). Superoxide anion (O2
•-
) is the primary ROS 
produced in mitochondria as a result of single electron transfer to oxygen in the 
respiratory chain. This species can directly attack biological molecules or be dealt with 
by native mitochondrial antioxidant defenses. O2
•-
 can thus be reduced to hydrogen 
peroxide (H2O2) and this to molecular water and oxygen, by the combined actions of the 
antioxidant enzymes Superoxide dismutase and Glutathione peroxidase, respectively. 
Under normal conditions, cells are able to deal with high levels of ROS through a 
variety of defense mechanisms. However, when ROS production overcomes the 
antioxidant defenses of the cell, this may cause transient or permanent damage to 
biological molecules. This cumulative damage can ultimately destroy the cell by 
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apoptosis or even necrosis. Within mitochondria, lipids, proteins, OXPHOS enzymes 
and mtDNA are particular vulnerable to free radicals (Pieczenik & Neustadt, 2007).  
 
 
1.2.3 Mitochondrial permeability transition  
Calcium (Ca
2+
) is a potent and ubiquitous second messenger, capable of regulating 
dozens of biological processes, including proliferation, gene transcription, post-
translational modification of proteins and aerobic metabolism (Rasola & Bernardi, 
2011). Researchers have a great interest in mitochondrial Ca
2+
 transport because of the 
central role of mitochondria and intramitochondrial Ca
2+
 in programmed cell death. 
Once inside the cell, Ca
2+
 may be sequestered by intracellular organelles such as 
mitochondria and endoplasmic reticulum (ER). The physiological increase in 
mitochondrial Ca
2+ 
has been observed to activate dehydrogenases coupled to the Krebs 
cycle as well as ATP synthase (Territo et al., 2000). This enhancement of enzymatic 
activity stimulates Krebs cycle and OXPHOS, and thus ATP synthesis.  
Calcium enters the matrix of mitochondria through two modes of inward transport, 
Ca
2+
 uniporter and the rapid mode or RaM (Gunter et al., 2000). On the other hand, 
calcium efflux from mitochondria takes place mainly through mitochondrial 
sodium/calcium exchanger but the high conductance ion channels like mitochondrial 
permeability transition (MPT) pore is another important mechanism for Ca
2+
 release. 
The ability of mitochondria to accumulate Ca
2+ 
is large but not infinite and when the 
limit is exceed there is a dramatic collapse of mitochondrial membrane potential which 
causes cessation of oxidative phosphorylation and ROS production; matrix swelling and 
cristae unfolding and rupture of the outer membrane with release of the accumulated 
Ca
2+ 
and of apoptogenic proteins (Rasola & Bernardi, 2011) 
The structure of the MPT pore is still a matter of intense debate, and its existence is 
not still completely demonstrated. What it is undoubtedly present is the phenomenon, 
the mitochondrial permeability transition. As the current model proposes, MPT pore is a 
multimeric protein channel complex formed by ANT, VDAC, peripheral 
benzodiazepine receptor (PBR), mitochondrial phosphate carrier, hexokinase (HK), 
creatine kinase (CK) and cyclophilin D (Cyclo D) (Figure 1.7) (Kroemer et al., 2007). 
Its opening increases membrane permeability to all solutes with molecular weight up to 
1.5 kDa, under certain conditions such as Ca
2+
 overloading, presence of inorganic 
Chapter I  General introduction 
18 
 
phosphate (Pi) and other factors including oxidative stress (Rasola & Bernardi, 2011). 
This channel is voltage- and Ca
2+
-dependent and cyclosporine A (CsA)-sensitive 
(Almofti et al., 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7- Induction of the mitochondrial permeability transition (MPT). The mitochondrial 
permeability transition (MPT) pore is a multimeric protein channel complex, between the inner and outer 
membranes, formed by the voltage-dependent anion channel (VDAC) on the outer mitochondrial 
membrane (OMM), the adenine nucleotide translocator (ANT) on the inner mitochondrial menbrane 
(IMM), and cyclophilin D (Cyclo D) in the matrix. Other proteins, such as the peripheral benzodiazepine 
receptor (PBR), hexokinase (HK) and creatine kinase (CK) are probably also involved in this 
phenomenon. Pathophysiological conditions, such as elevated Ca
2+
 concentrations, oxidative stress, ATP 
depletion and mitochondrial depolarization are known inducers of MPT, with consequent increase in the 
permeability of the IMM. The opening of the MPT pore ultimately results in mitochondrial swelling, 
mitochondrial Ca
2+
 efflux and the release of apoptogenic proteins, such as cytochrome c and procaspases, 
from the intermembrane space. ΔΨm, mitochondrial membrane potential; BAX, BCL2-associated X 
protein; ROS, reactive oxygen species (from Abou-Sleiman et al., (2006)). 
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The solute input to equilibrate ionic gradients of species with molecular mass lower 
than about 1.5 kDa leads to an increase in mitochondrial matrix volume due to water 
entry inside de mitochondria. This increase results in  mitochondrial swelling associated 
with membrane depolarization and uncoupling of the mitochondria, calcium release, 
unfolding of the inner membrane cristae and rupture of the outer membrane (Bernardi et 
al., 1999). The breaches in the outer membrane allows the release of cytochrome c and 
other apoptogenic proteins stored in the intermembrane space, which in turn can 
activate effector caspases and apoptotic dismantling of the cell. 
The general mitochondrial abnormalities linked with the phenomenon include 
mitochondrial electron transport chain impairment, anomaly in calcium homeostasis and 
alterations in mitochondrial morphology and dynamics. Their dysfunction can lead to a 
decline in energy production, generation of reactive oxygen species and induction of 
apoptosis. 
 
 
1.2.4 Cell death 
Necrosis and apoptosis are two different forms of cellular death. Whereas apoptosis 
requires a minimal amount of intracellular ATP, necrosis is generally accompanied by 
its total depletion (Kroemer et al., 2007). So, at least in part, the abundance of 
intracellular energy stores seems to be important to decide the form of cellular death.  
Necrosis is characterized by a gain in cell volume that leads to rupture of the plasma 
membrane and the unorganized dismantling of swollen organelles, while apoptosis is 
characterized by organized systematic steps leading to the dismantling of the entire cell 
with minimal leakage of cell constituents (Kroemer et al., 2007). 
Apoptosis is a crucial process of animal life that eliminates unwanted cells and is vital 
for embryonic development, homeostasis and immune defence (Ow et al., 2008). 
Apoptosis can occur mainly through two different pathways: the extrinsic and intrinsic 
pathway (Figure 1.8). The first one is mediated by death receptors (DR) located on the 
cell surface, induced by DR ligands (i.e., tumour necrosis factor (TNF-α), FasL), which 
originate death signals from the extracellular media to the inside of the cell. The 
intrinsic (or mitochondrial) pathway occurs in response to signals originated from inside 
the cell (Soane et al., 2007) such as DNA damage, metabolic stress or the presence of 
unfolded proteins.  
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Figure 1.8- Schematic representation of extrinsic and intrinsic pathways of apoptosis. Apoptosis can 
result from the activation of two distinct molecular cascades, known as the extrinsic (or death receptor) 
and the intrinsic (or mitochondrial) pathways. Both pathways, which can converge at the level of 
mitochondria, involve the activation of initiator caspases (caspase-8 and -9, respectively) that catalyze the 
proteolytic maturation of downstream executioner caspases, such as caspase 3, which are the final 
effectors of cell death. Mitochondrial outer membrane permeabilization (MOMP) represents the point-of-
no-return in the mitochondrial apoptotic pathway. Following MOMP, mitochondrial apoptogenic factors 
such as cytochrome c, Smac/Diablo or apoptosis inducing factor (AIF) are released to the cytosol. Once 
into the cytosol, these factors can initiate cell death in a caspase-dependent or a caspase-independent 
manner. MOMP is highly regulated by anti-apoptotic (e.g., Bcl-2 and Bcl-xL) and pro-apoptotic (e.g., 
Bax and Bak protein members of the Bcl-2 family) (from Nicholls & Fergunson, (2013)). 
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The formation of the mitochondrial outer membrane permeabilisation (MOMP) 
pore is an important feature of the intrinsic pathway. The pro-apoptotic proteins (Bax 
and Bak) attempt to undergo conformational changes, promoted by t-Bid and others 
BH3 proteins, to form homo-oligomers that constitute the MOMP pore. t-Bid makes an 
important converging point of both apoptotic pathways since it is important in the 
intrinsic pathway and is activated by caspase-8 in the extrinsic pathway from the Bid 
protein. 
Channel opening results in the loss of mitochondrial membrane potential (Δψ) and 
allows the release from the mitochondrial intermembrane space of pro-apoptotic 
proteins including cytochrome c, Omi/HtrA2 (Omi stress-regulated endoprotease/High 
temperature requirement protein A 2), second mitochondria-derived activator (Smac/ 
Diablo) and apoptosis-inducing factor (AIF) (Soane et al., 2007). The released 
cytochrome c will form an apoptosome together with the apoptotic protease-activating 
factor-1 (Apaf-1) and dATP. Assembly of the apoptosome creates a platform that bring 
together procaspase 9, enabling their autoactivation which then activates the executioner 
caspase-3 (Ow et al., 2008). Omi/HtrA2 and Smac/Diablo will neutralize the inhibitory 
effect of cytoplasmic inhibitor of apoptosis proteins (IAPs) leading also to activation of 
caspases.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter I  General introduction 
22 
 
1.3 Silver Nanoparticles and Mitochondria 
Once inside the body NPs can pass through cell membranes and interact with critical 
organelles such as mitochondria. Foley et al., (2002) demonstrated that NPs 
preferentially mobilize to mitochondria and may cause mitochondrial dysfunctions. 
Few studies have been made so far regarding the effects of silver nanoparticles on 
mitochondria and most of them are made on in vitro models. One of the few studies 
carried out ex vivo demonstrated that silver nanoparticles affected the bioenergetic 
features of the mitochondria, decreasing the mitochondrial membrane potential and 
impairing the oxidative phosphorylation capacity (Teodoro et al., 2011). 
As previously mentioned, Ag
+ 
has high affinity for thiol groups present in the 
cysteine residues. Therefore AgNPs disturb the mitochondria through interaction with 
thiol groups of inner mitochondrial membrane proteins (Almofti et al., 2003). AgNPs 
may oxidate thiol groups of important cell membrane proteins, causing changes in 
membrane permeability and disrupts mitochondrial functions. For instance, silver ions 
can bind with transport proteins leading to proton leakage, resulting in collapse of the 
proton motive force (Marambio-Jones & Hoek, 2010). Hussain et al., (2005) shown 
reduced mitochondrial function and increasing membrane leakage of rat liver cells after 
silver nanoparticles.  
AgNPs may affect mitochondria through impairments in ETC, causing ROS 
generation and affecting the production of ATP. As ATP is required for repair of DNA 
damages, reduction in its levels might impair energy-dependent DNA repair 
mechanisms (Asharani et al., 2009). Since the most of the mtDNA encodes for 
structural protein components of the ETC as well as two subunits of ATP synthase, 
damages on mtDNA have already been associated with defective electron transfer and 
ATP phosphorylation (Unfried et al., 2007). 
Induction of the apoptotic process has been also related with effects of AgNPs on 
mitochondria. Some studies have shown that treatment of cells with AgNPs activate a 
mitochondria-dependent apoptotic pathway. Jing et al., (2011) reported that AgNPs 
induced loss of mitochondrial, which in turn leads to release of cytochrome c.  This 
release initiates a cascade that leads to activation of caspase 9 and caspase 3, resulting in 
apoptosis. Activation of JNK was also present, and its inhibition through siRNA 
abolished cell death, suggesting that JNK is also involved in apoptotic process after 
AgNPs treatment. Another study of AgNPs toxicity carried out by Hsin et al., (2008) 
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suggested that apoptosis in fibroblast cells was mediated by a mitochondrial pathway. 
Generation of ROS by mitochondria activated apoptotic proteins, JNK and p53, which 
in turn induced Bax and consequently cytochrome c release. This enhancement of ROS 
production may cause oxidation of sulfhydryl groups of enzymes of the mitochondrial 
respiratory chain leading to mitochondrial dysfunction. 
In conclusion, figure 1.9 shows a possible mechanism of AgNPs toxicity. 
 
 
 
 
 
 
 
 
Figure 1.9- Possible mechanism of AgNPs toxicity. AgNPs can pass through cell membranes and 
interact with critical organelles such as mitochondria. Interaction with mitochondria may affect ETC, 
causing ROS generation and decrease GSH levels. The oxidative stress created might damage cellular 
components as well as lead to mitochondrial membrane permeability and disruption of mitochondrial 
functions. The loss of mitochondrial Δψ leads to release of cytochrome c and consequently activation of 
caspase 9 and caspase 3, resulting in apoptosis. (Image based on Jing et al., (2011)). 
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1.4 Objectives  
The development of the nanotechnology industry has increased the number of 
products containing nanoparticles. Many people can get exposed chronically to these 
NPs in a variety of manners such as researchers manufacturing the NPs, patients 
injected with NPs, or people using products containing NPs. Although nanomaterials 
are widely used in modern technology, there is a severe lack of information about their 
possible effects in human health and environment. So far, most of the information about 
the mechanisms of AgNPs toxicity has been derived from in vitro studies. Just a few 
studies have been conducted in vivo, reflecting a significant gap of information about 
the increasing concern to the human health. More so, these in vivo studies have utilized 
rather high doses of AgNPs in an acute exposure time frame. 
Thus, the main goal of this project is evaluate, in vivo and ex vivo, what are the 
consequences of AgNPs at low dose during a chronic exposure. We also intend to 
evaluate if, in these conditions, AgNPs interact with mitochondria, compromising its 
energetic functions. This approach can contribute to improve our knowledge about the 
mechanism by which AgNPs exert their toxicity, since this is the first time that AgNPs 
effects on mitochondria are evaluated at a low dose on a chronic exposure. 
Since AgNPs exposure has been related with ROS generation, it will be assessed if 
chronic exposure can increase oxidative stress in vivo and whether this increase can be 
prevented by antioxidant administration. Finally, since the size of the nanoparticles is 
one of the features that makes them unique and alters their behavior when compared to 
their bulk chemical counterpart, we pretend elucidate the influence of particle size on 
AgNPs toxicity. 
We expect that this work will contribute to improve our knowledge about the in 
vivo toxicity of AgNPs. In this way, allow help in delineating strategies to reduce or 
prevent this potential toxicity, taking into account that there is an exponential increase 
in the daily use of these NPs. 
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2.1 Materials and reagents 
Citrate-coated spherical silver nanoparticles were acquired from Nanocomposix 
(www.nanocomposix.eu). 
All other reagents and chemicals used were of the highest grade of purity 
commercially available. 
 
 
2.2 Animals, diets and treatments 
Male Sprague Dawley rats aged 10 weeks were purchased from Charles River 
Laboratories (France) and acclimated for 1 week before starting the experiments. They 
were housed under controlled light (12 h- light cycle) at 22 °C in a ventilated room. 
Food and water (pH 5.5) were supplied ad libitum. Animals were randomly selected and 
divided into 5 experimental groups (n=6 in each group):  
1- control group (saline injected);  
2- animals injected (once a week, during 1 month) with 250 µg/Kg AgNPs (size 10 
nm); 
 3- animals injected (once a week, during 1 month) with 250 µg/Kg AgNPs (size 75 
nm);  
4- animals treated with N-acetylcysteine (100 mg/Kg) 30 minutes before injection 
(once a week, during 1 month) with 250 mg/Kg AgNPs (size 10 nm);  
5- animals treated with N-acetylcysteine (100 mg/Kg) 30 minutes before injection 
(once a week, during 1 month) with 250 mg/Kg AgNPs (size 75 nm).  
All animals were intraperitoneally (i.p.) injected. 
All experimental procedures regarding the animals respected the institutional 
guidelines. 
 
 
2. 3 Plasma biochemical determination 
Blood samples were collected, before any animal treatment, by cutting the end of 
the tail. At the end of the study, animals were killed by decapitation and blood was 
again collected. Blood samples were mixed with EDTA and centrifuged at 2300 xg for 
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3 min. Plasma samples were collected and enzymatic determinations of alanine 
aminotransferase (ALT), aspartate aminotransferase (AST) and lactate dehydrogenase 
(LDH) performed using commercial kits. 
 
 
2.4 Isolation of liver mitochondria  
The animals were sacrificed by cervical dislocation and their liver was quickly 
removed. Liver was divided into 2 samples: for frozen tissue (immediately placed in 
liquid N2, and stored at -80°C until analysis) and for preparation of mitochondria. 
Hepatic tissue was finely minced in an ice-cold homogenization buffer (250 mM 
sucrose, 0.5 mM EGTA, 0.5% bovine serum albumin (BSA) and 10 mM HEPES, pH 
7.4). The buffer was renewed several times to remove excess of blood. Then, the tissue 
was homogenized with a “Potter-Elvejhem” type glass homogenizer and a Teflon piston 
(Figure 2.1). 
Mitochondria were isolated from the liver by differential centrifugation, as 
previously described (Rolo et al., 2009). Briefly, the homogenate was centrifuged 
(Sigma 3-18K Centrifuge) at 500 xg for 10 min at 4°C. This centrifugation was made to 
remove the heavier compounds in the homogenate (nucleus, cell fragments). 
Supernatant was collected and centrifuged at 10,000 xg for 10 min at 4°C to pellet 
mitochondria. Mitochondrial fraction was resuspended, using a brush, in a washing 
medium (250 mM sucrose and 10 mM HEPES, pH 7.4) and again centrifuged in the 
same condition. Mitochondria in the pellet were resuspensed in a final washing medium 
and immediately used. All operations were performed on ice during the isolation 
procedure.  
 
1. Homogenization  
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 2. Differential centrifugation  
 
 
 
 
 
 
 
 
 
 
 
3. Washing and purification  
 
 
 
 
 
 
 
Figure 2.1- Schematic representation of liver mitochondria isolation. 
 
 
2.5 Determination of protein concentration 
Protein concentration in mitochondrial preparation was determined by the biuret 
method (Gornall et al., 1949). A standard curve was prepared by dilution series of BSA 
(0; 1; 1.5 and 2 mg/mL) from 0.4% stock, H2O was added so that, together with BSA, 
the final volume was 0.5 mL. 50 µL of wash medium, 50 µL of DOC and 2 mL of 
biuret reagent were also added. 
Mitochondrial preparations (50 µL) were mixed with 50 µL of deoxycholate (DOC) 
(10%) to help protein solubilization. The amount of water to make a final volume of 0.5 
mL was added and then, 2 mL of biuret reagent. The standard curve and samples were 
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vortexed and placed at 37°C and allow to react for 10 minutes. Then, the samples and 
standard curve were transferred to cuvettes and the absorbance was measured at 540 
nm, using a Heλios spectrophotometer (ThermoElectronCorporation). 
 
 
2.6 Mitochondrial membrane potential measurements  
Mitochondrial membrane potential (Δψ) was estimated using an ion-selective 
electrode to measure the distribution of tetraphenylphosphonium (TPP
+
) according to 
previously established methods (Kamo et al., 1979), and using an Ag/AgCl electrode as 
reference. The entrance of TPP
+ 
in mitochondria was determined by TPP
+ 
concentration 
decreasing in the medium, measured by electrode potential (Figure 2.2). 
The potential difference generated between the selective electrode and the reference 
was measured with a Jenway electrometer (model 3305) and the output signal to a Kipp 
& Zonen recorder, after passing by a compensation circuit voltage basal (Madeira, 
1975). 
The TPP
+
 equilibrates passively across biological membranes until electrochemical 
equilibrium is reached, thus Δψ can be estimated from the following equation (at 25°C):  
 
Δψ (mV) = 59 log (v /V) - 59 log (10ΔE/59 -1), 
 
where v, V and E are mitochondrial volume, volume of the incubation medium, and 
deflection of the electrode potential from the baseline, respectively (Palmeira & Rolo, 
2012). A matrix volume of 1.1 µL/mg protein was assumed. 
Briefly, mitochondria (1mg) were suspended in an open chamber with constant 
stirring, at 25°C, in 1.3 mL of respiratory buffer (130 mM sucrose, 50 mM KCl, 5 mM 
MgCl2, 5 mM KH2PO4, 50 µM EDTA, 5 mM HEPES, pH 7.4) supplemented with 3 µM 
TPP
+
. This TPP
+
 concentration was used to achieve high sensitivity in measurements 
and to avoid possible toxic effects on mitochondria. Reactions were initiated by 
energizing mitochondria by adding 5 mM succinate. To avoid Complex I contribution 
due to possible endogenous substrates were added 3 µM of rotenone, a Complex I 
inhibitor. After the steady-state distribution of TPP
+
 occurred, ADP (200 nmol) was 
added to initiate the phosphorylative cycle.  
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Figure 2.2- TPP electrode. Membrane potentials are measured with a TPP
+
 electrode constructed by the 
use of a polyvinylchloride-based membrane containing tetraphenylboron as an ion-exchanger. 
 
 
2.7 Mitochondrial Respiration 
Oxygen consumption of isolated mitochondria was polarographically determined 
with a Clark oxygen electrode, as previously described (Rolo et al., 2009). Clark oxygen 
electrode, although only determines directly the rate of the final transfer of electrons to 
O2, provides a lot of information about mitochondrial processes by the simple 
arrangement of the incubation conditions. Substrate dehydrogenase activity, respiratory 
chain activity, adenine nucleotide transport across the membrane, ATP synthase 
activity, and H
+
 permeability of the membrane are some examples are the mitochondrial 
processes that might be investigated using the Clark oxygen electrode (Nicholls & 
Fergunson, 2013). The Clark oxygen electrode consists of two electrodes (platinum 
cathode and silver anode) immersed in the electrolyte (KCl) (Figure 2.3). O2 is reduced 
to H2O at the Pt electrode, which is maintained 0.7V negative with respect to the Ag/Cl 
reference electrode. The current flow is proportional to the O2 concentration in the 
medium. 
When KCl is the electrolyte occurs the following reactions: 
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Figure 2.3- The Clark oxygen electrode. This electrode records the current flowing between the 
platinum electrode and the silver reference electrode held 0.7V positive. The current is proportional to the 
oxygen tension. (Nicholls & Fergunson, 2013) 
 
 
Briefly, 1 mg of mitochondria was placed in an open chamber with constant 
stirring, at 25°C, in 1.3mL of the respiration buffer (as above) with rotenone (3µM) and 
succinate (5mM). 
The respiratory state 3 was initiated by the addition of ADP (200 nmol). After the 
phosphorylation of the ADP to ATP, respiratory rate became slower (state 4). The 
respiratory control ratio (RCR) was calculated by the ratio between the state 3 and the 
state 4 respirations and used as a parameter of mitochondrial integrity. 
The ADP/O ratio was calculated by the ratio between the amount of ADP added 
and the O2 consumed during the state 3 respiration, as previously reported by Chance & 
Williams (1956). 
Respiration in the presence of oligomycin was induced by the addition of ADP (200 
nmol) and oligomycin (1 µg/mg protein) to evaluate the proton leak through the inner 
mitochondrial membrane. Oligomycin is specific inhibitor of ATPase, which creates a 
non-phosphorylative respiration. 
Carbonyl cyanide 4-(trifluormethoxy) phenylhydrazone (FCCP)-uncoupled 
respiration was promoted by the addition of FCCP (1 µM). FCCP is an ionophore that 
uncouples oxidative phosphorylation by inducing artificial proton permeability in the 
mitochondria, stimulating the maximum respiration rate. 
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2.8 Succinate dehydrogenase activity 
Succinate dehydrogenase (SDH) (Complex II of electron transport chain) of activity 
was polarographically determined as previously described (Singer, 1974). The reaction 
was carried out in a chamber sealed, except for a small addition port, at 25 °C in 1.4 mL 
of standard respiratory medium (as in mitochondrial respiration) supplemented with 
5mM succinate, 2 μM rotenone, 0.1 μg antimycin A, 1mM KCN and 0.3 mg Triton X-
100. Rotenone, antimycin A and KCN were added to inhibit complexes I, III and IV, 
respectively. Thus, SDH is the only mitochondrial respiratory complex working in the 
ETC, being the oxygen consumption directly related with SDH activity. 
After the addition of freeze–thawed mitochondria (0.5 mg), 1 mM 
phenazinemetosulphate (PMS) was added to allow the initiation of the reaction. PMS is 
an intermediate electron acceptor which accepts electrons from SDH and transfers them 
to oxygen. Thus, the oxygen is reduced to H2O and the consequent decrease of oxygen 
concentration is detected by the Clark oxygen electrode. 
 
 
2.9 Cytochrome c oxidase (COX) activity 
COX activity was polarographically determined with a Clark oxygen electrode, as 
previously described (Brautigan et al., 1978; Varela et al., 2008). The reaction was 
carried out in a chamber sealed, except for a small addition port, at 25 °C in 1.4 mL of 
standard respiratory medium (as in mitochondrial respiration) supplemented with 2μM 
rotenone, 10 μM oxidized cytochrome c and 0.3 mg Triton X-100. After the addition of 
freeze–thawed mitochondria (0.5 mg), 5mM ascorbate plus 0.25mM 
tetramethylphenylene-diamine (TMPD) was added to allow the initiation of the 
reaction. Ascorbate is added as the reductant to regenerate TMPD from its oxidized 
form. TMPD donates electrons to the respiratory chain via cytochrome c. Cytochrome c, 
is mobile protein from the intermembrane space, which will reduce cytochrome c 
oxidase (Complex IV). Here, the electrons are transferred to the final electron acceptor, 
molecular oxygen (O2), generating H2O. The decrease of oxygen concentration is 
measured using the Clark oxygen electrode. 
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2.10 ATPase activity 
ATPase activity of the mitochondrial ATP synthase was spectrophotometrically 
determined at 660 nm, in association with ATP hydrolysis (Varela et al., 2008). The 
ATP synthase is a reversible enzyme that only runs in the direction of ATP synthesis by 
the continual regeneration of proton motive force (Δp) and the use of ATP by the cell. 
However, when this Δp is depressed, ATP synthase works as an ATPase, generating a 
Δp similar to that produce by the respiratory chain. The ATP hydrolysis yields inorganic 
phosphate (Pi), which can be measured by a simple colorimetric reaction. The amount 
of Pi produced by ATP hydrolysis is directly proportional to the activity of ATPase and 
was determined at 660 nm using a Heλios spectrophotometer 
(ThermoElectronCorporation). 
 Briefly, the reaction was carried out at 37°C, in 2 mL of reaction medium (125 
mM Sucrose, 65 mM KCl, 2.5 mM MgCl2, and 50 mM HEPES, pH 7.4). Mitochondria 
(0.25 mg) were added to reaction medium and the reaction was initiated by addition 2 
mM Mg
2+
-ATP, in the presence or absence of oligomycin (1 µg/mg protein). After 10 
min, the reaction was stopped by adding 1 ml of 40% trichloroacetic acid. 2 mL of 
ammonium molybdate (1%) plus 2 mL H2O were then added to 1 ml of reaction volume 
and reacted for 5 min at room temperature. ATPase activity was calculated as the 
difference in total absorbance and absorbance in the presence of oligomycin. 
 
 
2.11 Determination of ATP content 
Adenosine nucleotide extraction was performed as follows. Tissue samples were 
pulverized with a mortar and pestle in liquid N2 and homogenized in ice-cold KOH 
buffer (KOH 2.5M, K2HPO4 1.5 M), H2O, K2HPO4 1 M on ice. pH was adjusted to 7 
with HCl 1M and samples were vortexed and centrifuged at 18 000 xg for 2 min, at 4 
ºC. The supernatants were collected and frozen at -80 ºC for posterior use. Adenosine 
nucleotides were quantified with an ATP bioluminescent assay kit (Sigma- Aldrich) on 
a Victor
3
 plate reader. 
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2.12 Evaluation of reactive oxygen species (ROS) generation 
ROS production was determined fluorometrically using a Perkin-Elmer VICTOR
3
 
plate reader fluorometer (Zhou et al., 2001). 2',7'-dichlorodihydrofluorescein diacetate 
(H2DCFDA) is a nonfluorescent probe which easily crosses the cell membrane and once 
within the cell, the acetate groups are removed by intracellular esterases. Upon 
oxidization by ROS, the nonfluorescent H2DCFDA is converted to the highly 
fluorescent 2′,7′-dichlorofluorescein (DCF). DCF has an excitation wavelength of 485 
nm and an emission wavelength of 538 nm, and thus it can be detected using a 
fluorometer. Therefore, the fluorescence emitted by DCF is used as an indicator of 
reactive oxygen species (ROS) generation. 
Briefly, isolated mitochondria (1 mg/ml) were suspended in standard respiratory 
médium (130 mM sucrose, 50 mM KCl, 5 mM MgCl2, 5 mM KH2PO4, 50 μM EDTA, 
5 mM HEPES (pH 7.4), and 3 μM rotenone) loaded with 50 μM H2DCFDA (in DMSO) 
for 15 min at 25ºC. After incubation, the samples were spun at 3000 rpm for 3 min and 
the resultant pellet was suspended in medium. 200 μl of the mitochondrial suspension 
were loaded into a 96-well plate and the fluorescence monitored. After basal 
fluorescence measurement, antimycin A was added to all preparation to block complex 
III of the mitochondrial chain, to induce maximal ROS generation. The results were 
expressed as relative fluorescence units (RFUs). 
 
 
2.13 Mitochondrial permeability transition (MPT) 
Mitochondrial swelling was estimated by changes in light scattering, as 
spectrophotometrically monitored in a Heλios spectrophotometer 
(ThermoElectronCorporation) at 540 nm (Palmeira and Wallace, 1997). The 
experiments were started by the addition of mitochondria (1 mg) to a final volume of 2 
mL of the standard incubation medium (200 mM sucrose, 10 mM HEPES (pH 7.4), 1 
mM KH2PO4 and 10 µM EGTA) supplemented with 3 μM rotenone and 5 mM 
succinate and, in selected assays, Cyclosporin A 1 µM, a known mPT inhibitor as a 
negative control. The reaction temperature was maintained at 25ºC. After a brief 
incubation period to establish a baseline absorbance, different calcium concentrations 
were added as indicated by the arrows in the figure, to induce permeability transition. 
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2.14 Western Blotting analysis 
The mitochondrial content of COX-I, COX-IV and tubulin were determined by 
western blotting. Tissue samples were pulverized with a mortar and pestle in liquid N2 
and homogenized in ice-cold lysis buffer supplemented with a protease inhibitor. Equal 
amounts of protein (50 µg) were mixed with Laemmli sample buffer and heat-
denaturation was performed immediately prior to one-dimensional gel electrophoresis. 
Proteins were separeted on 15% SDS-polyacrylamide gel, using a Mini-Protean 
electrophoresis system (Bio-Rad Laboratories, Inc., CA, EUA) for 90 minutes, 100 V, 
with electrophoresis buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3) 
The proteins were transferred to polyvinylidene difluoride (PVDF) membrane for 
90 minutes, 100 V, using transfer buffer (25mM Tris, 192 mM glycine, 20% methanol, 
pH 8.3), under magnetic stirring. The transfer occurred in Mini Trans-Blot (Bio-Rad 
Laboratories, Inc., CA, EUA) placed in ice. 
Membranes were blocked in TBS (25 mM Tris-HCl (pH 7.6) and 150 mM NaCl) 
supplement with 5% nonfat milk for 2 hours. After the blockage, membranes were 
washed with TBS-T (TBS supplement with Tween-20 1%) and then, incubated with 
anti-COX I (1:100), anti-COX IV (1:1000) or anti-tubulin (1:5000) overnight at 4ºC 
with gentle shaking. Immunodetection was performed with Western-Dot 625 
(Invitrogen) goat anti-rabbit or goat anti-mouse western blot kits. Membranes were 
imaged using a Gel Doc instrument (Biorad) and the densitometric analysis was 
performed with the ImageJ software.  
 
 
Table II- List of utilized antibodies for Western blot, source and utilized dilution. 
 
 
 
 
Antibody Specie Dilution Supplier Reference 
Tubulin Rabbit 1:5000 Abcam ab52866 
COX-I Mouse  1:100 MitoSciences MS404 
COX-IV Mouse  1:1000 MitoSciences MS407 
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2.15 Statistic analyses 
Data are presented as mean ± S.E.M. Statistical significance was determined using 
one way ANOVA followed by Bonferroni post-hoc test. A value of p<0.05 was 
considered as statistically significant. 
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3.1 Food consumption and effect on body weight 
In order to evaluate the effect of AgNPs administration in terms of food 
consumption and body weight gain, the food intake as well as the animals weights were 
measured once a week.  
 A) 
 
 B) 
 
Figure 3.1- Food intake (A) and animal total body weight progression (B) throughout the study. 
Data are means ± S.E.M of experiments performed with six animals/group(p<0.05).* indicates 
statistically significant difference between 10 nm and control; & indicates statistically significant 
difference between 10 nm and 75 nm+NAC; $ indicates statistically significant difference between 10nm 
and 75 nm; # indicates statistically significant difference between 10nm+NAC and 75 nm+NAC; % 
indicates statistically significant difference between 10 nm and 10 nm+NAC. 
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As can be seen in Figure 3.1 A, the food intake of 10nm-AgNPs group was 
significantly higher than the others experimental groups throughout the study even 
before the nanoparticles administration. Regarding body weight progression, 10nm-
AgNPs group showed a significant increase after the first week until the end of the 
experiment (Fig.3.1 B) 
 
 
3.2 Plasma markers of liver injury 
To determine if silver nanoparticles induced liver injury, serum levels of ALT, AST 
and LDH were evaluated. As shown in Figure 3.2 A and B, all groups significantly 
increased plasma ALT and AST levels after 4 weeks of treatment (T4) compared to the 
begin of the experiment, before any treatment (T0). Administration of NAC was 
effective in reducing the increase in plasma levels of AST caused by 10nm-AgNPs on 
T4. Plasma LDH levels were also significantly increased on T4 in groups with both 
sizes of silver nanoparticles compared to T0. Administration of NAC was effective in 
reducing the increase in plasma levels of LDH caused by 75nm-AgNPs on T4. 
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A)  B) 
 
      C) 
 
 
 
 
 
 
 
 
Figure 3.2- The effect of silver nanoparticles on plasma levels of (A) alanine aminotransferase 
(ALT), (B) aspartate aminotransferase (AST) and (C) lactate dehydrogenase (LDH). Plasma 
samples were collected and enzymatic determinations of ALT, AST and LDH performed using 
commercial kits. White columns represent plasma collected in the beginning of the study, before any 
administration (T0). Black columns represent plasma collected at the end of the study, after all 
administrations (T4). Data are means ± S.E.M of experiments performed with five 
animals/group(p<0.05). *indicates statistically significant difference between white and black columns in 
the same experimental group; # indicates statistically significant difference between 10 nm and 10 
nm+NAC @ indicates statistically significant difference between 75 nm and control; & indicates 
statistically significant difference between 75 nm and 10nm+NAC; $ indicates statistically significant 
difference between 75 nm+NAC and 75 nm.  
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3.3 Mitochondrial membrane potential 
Membrane potential (Δψ) sustained by mitochondria is fundamental for 
mitochondrial function. Results are summarized in Table III. 
 
Table III- Effects of silver nanoparticles in mitochondrial membrane potential. 
Mitochondrial membrane potential (Δψ) determined in the presence of succinate as respiratory substrate. 
Reactions were carried out in 1.3 mL of reaction medium, supplemented with 3 µM rotenone and 1 mg of 
freshly isolated mitochondria, as described in Materials and Methods chapter. Data are means ± SEM of 
experiments performed with six different mitochondrial preparations(p<0.05). *indicates statistically 
significant difference versus control; # indicates statistically significant difference versus 10 nm; $ 
indicates statistically significant difference versus 75 nm. 
 
 
 
Δψ significant decreased in mitochondria exposed to either 10- or 75-nm AgNPs 
(Table III). A significantly alteration was seen in 75nm+NAC group when compared to 
10- and 75 nm. Depolarization induced by the addition of ADP and Δψ after 
repolarization (mitochondrial capacity to establish Δψ after ADP phosphorylation) also 
decreased in mitochondria exposed to both sizes of AgNPs. 
When pretreated with NAC, the mitochondria showed a significantly higher 
mitochondrial Δψ after repolarization when compared with the same conditions without 
NAC. Another important difference regarding mitochondrial Δψ after repolarization 
was seen between both AgNPs sizes. 75nm- was significantly higher than 10nm-
AgNPs. 
Finally, the lag phase (time necessary for ADP phosphorylation) was significantly 
longer in the presence of both sizes of AgNPs, illustrating a clear impairment of 
mitochondrial function (Figure 3.3). Once again, NAC was able to combat such effect. 
 
Control  10 nm 10 nm + NAC 75 nm 75 nm + NAC 
Initial Δψ (-mV) 216.20 ± 
 2.20 
197.50 ± 
 3.77 * 
212.30 ±  
0.96# 
205.00 ±  
1.20* 
214.60 ±  
0.55#$ 
Δψ Depolarization (-mV) 30.16 ±  
0.71 
23.61 ± 
0.71* 
26.76 ± 
 0.40 
25.78 ± 
0.89* 
29.10 ±  
1.05# 
Δψ Repolarization (-mV) 
214.90 ±  
2.25 
191.20 ± 
3.60* 
209.50 ±  
1.13# 
201.80 ± 
1.26*# 
211.40 ± 
 0.55#$ 
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Figure 3.3- Effects of silver nanoparticles in the lag phase preceding the mitochondrial 
repolarization. Mitochondrial lag phase was performed with the TPP
+
-selective electrode. Data are 
means ± SEM of experiments performed with six different mitochondrial preparations(p<0.05). *indicates 
statistically significant difference versus control; # indicates statistically significant difference versus 10 
nm; $ indicates statistically significant difference versus 75 nm. 
 
 
3.4 Mitochondrial respiration/oxygen consumption 
The possible alterations caused by AgNPs in oxidative phosphorylation and 
respiratory chain were investigated. Mitochondrial state 3 respiration (ADP-induced 
oxygen consumption) was significantly decreased in mitochondria exposed either size 
of silver nanoparticles, an effect reversed by NAC (Table IV). The consumption of 
oxygen after ADP phosphorylation (state 4 respiration) was slightly increased in 
mitochondria exposed to 10nm-AgNPs and significantly increased with 75nm-AgNPs. 
However, in the presence of NAC, state 4 respiration of 75nm-AgNPs group was 
significantly decreased. Consequently, the ratio between state 3 and state 4 respiration 
(RCR), was significantly decreased in mitochondria exposed to either size of AgNPs.  
The ADP/O ratio, an indicator of oxidative phosphorylation efficiency, showed a 
significantly decrease when mitochondria were exposed to either AgNPs sizes. 
However, once again NAC significantly reverted this effect. 
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Table IV- Oxygen consumption measurements. State 3 respiration, state 4 respiration, respiratory 
control ratio (RCR), ADP/O, Oligomycin-inhibited oxygen consumption (v Oligomycin) and FCCP-
stimulated oxygen consumption (v FCCP) in liver mitochondria, upon incubation with silver 
nanoparticles. Reactions were carried out in 1.3 mL of reaction medium, supplemented with 3 µM 
rotenone and 1 mg of freshly isolated mitochondria, as described in Materials and Methods chapter. Data 
are means ± SEM of different experiments performed with six different mitochondrial 
preparations(p<0.05). *indicates statistically significant difference versus control; # indicates statistically 
significant difference versus 10 nm; $ indicates statistically significant difference versus 75 nm; & 
indicates statistically significant difference versus 10nm+NAC. 
 
 
Mitochondrial respiration under non-phosphorylative conditions was also evaluated 
in the presence of oligomycin, a specific inhibitor of ATP synthase. Mitochondria 
exposed to either size of silver nanoparticles were significantly increased when 
compared to control. 75nm+NAC group was significantly lower when compared to the 
same condition without NAC (75nm group). 
Oxygen consumption was stimulated by v FCCP, a well-known respiratory chain 
uncoupler. The results show a significant decrease in all experimental groups when 
compared to control. However, the presence of NAC prevented AgNPs deleterious 
action, shown by the significant increase in the FCCP-uncoupled respiration. 
 
 
 
 
Control   10 nm 10 nm + NAC 75 nm 75 nm + NAC 
State 3 
(nAtoms O/min/mg protein) 
151.5 ± 
12,75 
85.1 ± 
5.65* 
120.2 ±  
9.01# 
92.87± 
7.14* 
151.1 ± 
7.89#$ 
State 4 
(nAtoms O/min/mg protein) 
34.7 ± 
1.37 
44.8 ± 
2.26 
41.73 ± 
4.45 
54.46± 
5.26* 
39.16 ± 
2.76$ 
RCR 
3.35 ± 
0.28 
2.17 ± 
0.08* 
2.675 ± 
0.38 
2.153± 
0.19* 
3.293 ± 
0.09#$ 
ADP/O 
1.75 ± 
0.012 
1.22 ± 
0.039* 
1.49 ± 
0.029# 
1.18 ± 
0.024*& 
1,58 ± 
0,082#$ 
 v Oligomycin 
(nAtoms O/min/mg protein) 
33.57 ± 
4.06 
57.1 ± 
4.87* 
51.97 ± 
1.60* 
61.93± 
3.72* 
41.00 ± 
2.62#$ 
v FCCP 
(nAtoms O/min/mg protein) 
259.1 ± 
12.13 
109.8± 
3.29* 
202.3 ± 
20.7*# 
140.4 ± 
10.14*& 
204.7 ± 
9.86*#$ 
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3.5 ATPase activity 
The enlarged lag phase in mitochondria exposed to AgNPs suggested that this 
exposure could affect ATPase, a key component of the phosphorylative system. In order 
to clarify this alteration, mitochondrial ATPase activity was evaluated (Fig.3.4). Both 
mitochondria ATPase activity exposed to either size of silver nanoparticles were 
significantly decreased when compared to control. 75nm+NAC group showed values of 
ATPase activity similar to the control group suggesting that NAC prevented AgNPs 
deleterious action against ATPase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4- ATPase activity in liver mitochondria. ATPase activity was spectrophotometrically 
determined at 660 nm and was calculated as the difference in total activity and activity in the presence of 
oligomycin. Data are means ± S.E.M of experiments performed with six animals/group(p<0.05). 
*indicates statistically significant difference versus control; # indicates statistically significant difference 
versus 10 nm; $ indicates statistically significant difference versus 75 nm; & indicates statistically 
significant difference versus 10nm+NAC 
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3.6 Adenine nucleotides content 
The decreased ATPase activity in mitochondria isolated from animals injected with 
both AgNPs sizes may suggest problems in ATP phosphorylation. To further determine 
whether AgNPs affect mitochondrial ATP production, endogenous ATP content was 
evaluated. As can be seen in Figure 3.5, both AgNPs sizes showed value similar to the 
control group. However, in the presence of NAC, ATP content levels tend to be slightly 
higher. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5- The effect of silver nanoparticles on ATP content. ATP content was evaluated by using a 
bioluminescent assay kit as described on Materials and Methods chapter. Data are means ± S.E.M of 
experiments performed with five animals/group. 
 
 
3.7 Enzymatic activities 
The decreased rate of oxygen consumption induced by FCCP in mitochondria 
isolated from animals injected with either size of AgNPs suggested alterations in the 
mitochondrial electron transport chain complexes. In view of this, succinate 
dehydrogenase (SDH) and cytochrome c oxidase (COX) activities were evaluated. 
As expected, both AgNPs sizes exhibited significantly decreased activities in SDH 
when compared to control (Fig.3.6 A). NAC was able to significantly increase this 
enzyme activity in the presence of 75nm-AgNPs. 
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COX activity significantly decreased in mitochondria exposed to 75nm-AgNPs 
comparing to control. This effect was recovered in the presence of NAC (Fig.3.6 B). 
The administration of 10nm-AgNPs showed a slight decrease when compared to 
control, which was significantly recovered in the presence of NAC.  
 
 
A)  B) 
 
 
 
 
 
Figure 3.6- (A) Succinate dehydrogenase activity; (B) Cytochrome c oxidase activity in liver 
mitochondria incubated with silver nanoparticles. Enzyme activity was polarographically measured 
using a Clark oxygen electrode as described in Materials and Methods chapter. Data are means ± S.E.M 
of experiments performed with six animals/group(p<0.05). *indicates statistically significant difference 
versus control; # indicates statistically significant difference versus 10 nm; $ indicates statistically 
significant difference versus 75 nm; & indicates statistically significant difference versus 10nm+NAC. 
 
 
3.8 Generation of reactive oxygen species (ROS) 
Both in vivo and in vitro studies have shown that AgNPs lead to ROS production 
(Arora et al., 2008; Carlson et al., 2008; Ghosh et al., 2012; Tiwari et al., 2011). In 
order to assess if our data also shown a similar effect, the evaluation of the ROS 
production in mitochondria exposed to AgNPs was performed. 
For both AgNPs sizes tested, ROS production rate was significantly increased when 
compared to the control group, either in the presence or absence of antimycin A (Fig. 
3.7).  Mitochondria isolated from the livers exposed to NAC revealed statistically non-
significant trend towards decreased ROS production in both sizes of AgNPs. 
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A) B) 
 
 
 
 
 
 
Figure 3.7- The effects of silver nanoparticles on reactive oxygen species (ROS) generation. ROS 
were estimated fluorometrically using the probe H2DFDA, as described in Materials and Methods 
chapter. A) After basal fluorescence measurement, Antimycin A was added to all preparations (B) to 
block complex III of mitochondrial respiratory chain, and so to induce heightened ROS generation. Data 
are means ± S.E.M of experiments performed with six animals/group(p<0.05). *indicates statistically 
significant difference versus control.  
 
 
3.9 Mitochondrial permeability transition 
Mitochondrial calcium retention capacity is an important component of 
mitochondrial function. Although the ability of mitochondria to accumulate Ca
2+
 is 
somewhat high, it is not infinite (Chalmers & Nicholls, 2003). Mitochondria show a 
finite capacity of accumulating calcium and, after a certain threshold, undergo the 
mitochondrial permeability transition (MPT), possibly through the formation of a 
multichannel pore (Rasola & Bernardi, 2011). Several factors can induce MPT, such as 
increased ROS generation, decreased ATP content and high calcium concentration. This 
threshold varies, in accordance with several mitochondrial parameters, as the 
mitochondria’s membrane potential, among others. The simplest way to observe the 
MPT with isolated mitochondria is to follow the decrease in light scattering of the 
suspension as the mitochondrial matrix swells and the outer membrane ruptures. The 
faster the decrease in absorption, the worse the mitochondrial calcium retention 
capacity. As such, the amount of calcium mitochondria can accumulate and for how 
long is an extremely useful indicator of mitochondrial function. 
 
C
tl
10
nm
10
nm
+N
A
C
75
nm
75
nm
+N
A
C
0
50
100
150
200
*
*
R
O
S
 g
e
n
e
ra
ti
o
n
 (
b
a
s
a
l)
C
tl
10
nm
10
nm
+N
A
C
75
nm
75
nm
+N
A
C
0
50
100
150
200
*
*
R
O
S
 g
e
n
e
ra
ti
o
n
 (
A
A
)
Chapter III  Results 
51 
 
A)   B) 
  
C) D) 
 
Figure 3.8- The effects of silver nanoparticles on the susceptibility to the induction of mitochondrial 
permeability transition (MPT). Mitochondrial swelling was spectrophotometrically monitored at 540 
nm. Experiments were started by the addition of mitochondria (1 mg) to 2 ml of reaction medium 
supplemented with 3 μM rotenone and 5 mM succinate. After a small period of time to obtain a basal 
absorbance reading, 10 (A, C) and 20nmol (B, D) of calcium were added to individual preparations. The 
traces are representative of experiments performed with six independent mitochondrial 
preparations(p<0.05). *indicates statistically significant difference between silver nanoparticles and 
control; # indicates statistically significant difference between silver nanoparticles with and without NAC. 
 
 
Mitochondria isolated from animals injected with either with 10 nm- or 75 nm- 
AgNPs were significantly more susceptible to calcium-dependent mitochondrial 
swelling, relative to the control (Fig. 3.8). NAC supplementation was significantly able 
to recover the calcium retention capacity in both sizes and doses of calcium. Pre-
incubation with cyclosporine A (CyA), a MPT specific inhibitor, completely prevented 
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calcium-dependent mitochondrial swelling, indicating that the decrease in absorbance 
was the result of calcium-induced MPT. 
 
 
3.10 Protein Content 
Since AgNPs affected COX activity, COX-I and COX-IV content were evaluated 
(Figure 3.9). Both proteins are subunits of Cytochrome c oxidase, being COX-I encoded 
by mitochondrial DNA whereas COX-IV is one of the nuclear-coded polypeptide 
chains. Mitochondria exposed to either size of AgNPs revealed statistically non-
significant trend towards increased COX-I and -IV content (Figure. 3.10). However, 
when pretreated with NAC, 75nm-AgNPs show a significant decrease in COX-IV 
content. 
 
 
 
 
 
 
 
Figure 3.9- COX-I, COX-IV and tubulin content in liver homogenates were evaluated by western 
blotting. A representative blot from four independent experiments is shown. 
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A) B) 
 
Figure 3.10- Densitometric analysis of COX-I (A) and COX-IV content (B). Data are means ± S.E.M 
of experiments performed with four animals/group(p<0.05). *indicates statistically significant difference 
versus 75 nm. 
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Nanomaterials have been of extreme importance to the industry due to the 
beneficial physicochemical features they have compared to bulk parental materials. 
Enhanced surface area, tunable size, modifiable surface chemistry and particle reactivity 
are some of the most important physicochemical properties that nanomaterials possess. 
These features give them improved thermal and/or electrical conductivity, improved 
catalytic activity and advanced optical properties (N. Singh et al., 2009). The 
development of nanotechnology is creating a broad array of nanoparticles that are 
already incorporated into a wide variety of consumer products. In 2011, more than 300 
products containing nanosilver were available on the market (Gaiser et al., 2013) and as 
this number increases, the inevitable human exposure tends to rapidly expand, 
accompanied by potential for adverse health effects. Thus, there is a large international 
effort underway to verify nanoparticle safety upon the environment and human health. 
However, limited information is available about this concern thus far.  
Silver is known for its antibacterial properties, giving AgNPs wide use in 
antimicrobial coatings, wound dressings, surgical instruments and more recently in 
biomedical devices that continuously release a low level of silver ions protecting against 
bacteria. Over the last years, nanoparticles have been the subject of intense research for 
use in biomedicine, namely as biosensors, drug-delivery agents and imaging contrast 
agents, which take advantage of their unique optical properties. Thus, due to the 
increasing use of AgNPs, biomedicine might be becoming the major source of human 
exposure to AgNPs. Besides injection, human exposure can occur via inhalation, 
ingestion and dermal contact (Ahamed et al., 2010; Lee et al., 2013). 
For any exposure routes involving translocation to the bloodstream, the liver is one 
of the most important targets (Gaiser et al., 2013). Sadauskas et al. (2007) showed that 
Kupffer cells are essential for particle removal following intravenous administration. 
Recent studies on the biodistribution of AgNPs after injection demonstrated that the 
liver is the primary site of AgNPs deposition (Dziendzikowska et al., 2012; Lee et al., 
2013). A study carried out by Sarhan & Hussein, (2014) showed a large number of 
lysosomes filled with AgNPs as well as complete loss of mitochondrial cristae in 
Kupffer cells. Therefore, the liver was chosen as a target organ in this study to identify 
adverse effects of AgNPs. As the liver is one of the main organs of nanoparticles 
deposition, certain adverse effects can occur due to AgNPs accumulation such as 
pathological changes in liver morphology, generation of ROS, DNA damage and 
changes in liver enzyme activities (Tiwari et al., 2011). The level of particular enzymes 
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in blood serum is a good indicator of liver injury (Tiwari et al., 2011) and our data 
shows that AgNPs were capable of increasing plasmatic AST and LDH activities. The 
AgNPs exposure could induce changes of cell shape, reduce cell viability and increases 
LDH release (Zhang et al., 2014). The LDH release is related with cell membrane 
damage, which along with increased plasmatic AST activity, a good biomarker of 
hepatocellular level damages, suggests hepatocellular injury induced by AgNPs 
exposure (Figure 3.2). 
As a heavy metal, silver displays a strong affinity for thiol (-SH) groups present in 
biomolecules found throughout the body like reduced GSH and proteins, such as 
thioredoxin, SOD and thioredoxin peroxidase (T. Zhang et al., 2014). Therefore, AgNPs 
might cause an imbalance on human health due to an increase of oxidative stress. 
Miyayama and colleagues have shown that AgNO3 increased the generation of ROS in 
mitochondria and altered the levels of antioxidant agents (Miyayama et al., 2013). There 
are also many other molecules that contain thiols in the cytoplasm, cell membrane and 
inner mitochondrial membrane. Silver can also interact with inner mitochondrial 
membrane proteins causing changes in membrane permeability and disruption of 
mitochondrial functions.  
Since the major reason for AgNPs toxicity is the increase of oxidative stress, 
antioxidant therapy might be a viable strategy for attenuating this toxicity. It has been 
reported that the effects of Ag
+
 on mitochondria can be blocked by the addition of 
antioxidant scavengers like GSH (Almofti et al., 2003). GSH plays a major role in 
cellular protection against oxidative stress due to its ability to bind and neutralize ROS 
(Hsin et al., 2008). Being a precursor of GSH’s synthesis (Chairuangkitti et al., 2013), 
NAC was used in our study to understand whether oxidative stress caused by AgNPs 
can be prevented by an antioxidant. Some studies found that the pretreatment with NAC 
prevented AgNPs toxicity in human liver cells (Jing et al., 2011; Kim et al., 2009).  
As previously mentioned, size is one of the main features that provide NPs unique 
properties. As the size decreases, there is an increase on the surface area/volume ratio, 
which enhances the catalytic activity of NPs leading to a higher reactivity upon other 
molecules (N. Singh et al., 2009). This larger surface area has also been related with 
enhancing release of toxic silver ions from the particle surface (Foldbjerg & Autrup, 
2013). Furthermore, smaller AgNPs can cross biological barriers more efficiently than 
the larger ones allowing heightened interaction with biomolecules and critical 
organelles such as mitochondria. In accordance with these evidences, several studies 
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reported that smaller AgNPs induce more cytotoxicity than larger AgNPs (Ahamed et 
al., 2008; Carlson et al., 2008; Monteiller et al., 2007). To assess the influence of 
particle size upon the in vivo effect of AgNPs, two different sizes (10- and 75-nm) were 
used in our studies. Overall, 10nm-AgNPs show more cytotoxicity throughout the study 
than 75 nm-AgNPs. This effect will be discussed in more details below.  
Being mitochondria the most important organelle in the cell in terms of energy 
metabolism, the next logical step was to understand how AgNPs administration would 
affect hepatic mitochondria. Previous studies have reported decreased mitochondrial Δψ 
using in vitro (Sahu et al., 2014) or ex vivo (Teodoro et al., 2011) models. As expected, 
AgNPs severely affect mitochondrial bioenergetics and function in our study. The 
results demonstrate that in isolated rat liver mitochondria, both sizes (10- and 75-nm) of 
AgNPs decreased mitochondrial initial potential, depolarization potential as well as 
repolarization potential (Table III). Two mechanisms are possible to explain this Δψ 
decrease: (i) proton (H
+
) leak, increase of inner mitochondrial membrane permeability 
to H
+
 and (ii) H
+
 slip, decrease number of H
+
 ejected coupled with deficient electron 
transport through the respiratory chain (Brookes, 2005; Murphy, 1989). The analysis of 
lag phase time, this is the time necessary for ADP phosphorylation, revealed significant 
increases in animals’ mitochondria exposed with both sizes of AgNPs (Figure. 3.3). 
Moreover, both sizes caused a severe decrease in state 3. The state 3 is established 
when a small amount of ADP is added to a mitochondrial preparation, allowing the 
function of ATP synthase. The H
+
 re-entry causes a proton motive force decrease and 
electron transport acceleration leading to oxygen consumption increase. Thus, these 
results suggest that both sizes of AgNPs impaired the oxidative phosphorylation 
capacity of hepatic mitochondria as also shown by the decreased respiratory control 
ratio (RCR) (Table IV). The RCR is the single most useful general measure of function 
in isolated mitochondria. Generally speaking, high RCR indicates good function and 
implies that the mitochondria have a high capacity for substrate oxidation and ATP 
turnover and low proton leak. On the other hand, low RCR usually indicates 
dysfunction as changes in oxidative phosphorylation (Brand & Nicholls, 2011). 
State 4 and vOligomycin respiration rates were also affected (Table IV). State 4 is 
achieved when all ADP added is converted to ATP leading to proton motive force 
increase, end of proton re-entry through ATP synthase and consequent mitochondrial 
respiration decreasing. On the other hand, oligomycin is a specific inhibitor of ATPase, 
blocking the proton re-entry through ATP synthase and decreasing mitochondrial 
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respiration, even in the presence of unphosphorylated ADP. In both conditions there is a 
respiration decrease due to proton gradient reestablishment caused by the activity of the 
respiratory chain. State 4 and vOligomycin respiration are controlled by the activity of 
the proton leak (Brand & Nicholls, 2011). As our data shows an increase in both 
respiratory rates, this suggests that AgNPs exposure did affect the inner mitochondrial 
membrane permeability to protons, consequently creating dissipation of membrane 
potential and heightened rate of respiration to regenerate Δψ. This increase of inner 
mitochondrial membrane permeability can be related with the ability of silver ions to 
bind with transport proteins causing protonic leakage, resulting in the collapse of the 
proton motive force (Marambio-Jones & Hoek, 2010). The increase state 4 and 
vOligomycin respiration due to H
+
 leak suggests this phenomenon as the main 
responsible for mitochondrial Δψ decrease. As previously mentioned AgNPs exposure 
increases ROS production (Arora et al., 2008; Carlson et al., 2008; Tiwari et al., 2011) 
It has been reported a close relationship between ROS generation and H
+
 leak. ROS can 
induce lipidic oxidation in inner mitochondrial membrane which in turn can lead to H
+
 
leak (Brookes, 2005). Therefore, ROS generation due to AgNPs exposure can be the 
main responsible for the inner mitochondrial membrane permeability increasing. 
Mitochondria exposed to AgNPs show a significant recovering in mitochondrial Δψ, 
state 4 and vOligomycin respiration when pretreated with NAC. This result suggests 
that NAC was able to prevent ROS generation induced by AgNPs exposure, avoiding 
lipidic oxidation and mitochondrial permeability. The results are in agreement with that 
reported previously by Hiura et al., (2000) showing that NAC blocked the 
mitochondrial membrane potential decrease. 
ADP/O, an indicator of OXPHOS efficiency, was also significantly decreased 
(Table IV). ADP/O ratio represents the coupling between the use of oxygen by the 
electron transport chain and the ADP phosphorylated by ATP synthase. Changes in 
ADP/O values are related with alteration in the coupling mechanism, for instance, the 
respiratory complexes slip and pump fewer protons than normal (Brand & Nicholls, 
2011). Therefore, ADP/O ratio decrease along with increasing lag phase suggests an 
uncoupling between the oxidative capacity by the electron transport chain and the 
phosphorylation of ADP to ATP by the ATP synthase. So it was reasonable to assume 
that somewhere along the respiratory chain, AgNPs were causing an impairment of the 
electronic flux through the respiratory chain. This was confirmed by the fact that 
AgNPs caused a severe decrease in vFCCP respiration in all experimental groups when 
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compared to control (Table IV).  The decrease of vFCCP respiration associated with the 
depressed state 3 suggests possible alterations in the mitochondrial electron transport 
chain complexes’ function. This hypothesis is supported by Almofti et al., (2003), who 
reported that Ag
+ 
might affect mitochondria through interaction with -SH groups of 
inner mitochondrial membrane proteins, leading to impairments in ETC. A recent study 
found that all four mitochondrial electron transport chain complexes were significantly 
affected by exposure to Ag
+ 
(Miyayama et al., 2013).  
Once again, in our study, NAC administration was effective in the prevention of the 
AgNPs effects. When pretreated with NAC, mitochondria exposed with AgNPs show a 
significant recovering in ADP/O ratio, vFCCP and state 3 respiration. Thus, this result 
suggests that NAC prevent the effects of AgNPs upon the mitochondrial electron 
transport chain complexes. It is well established that AgNPs exposure increase the ROS 
generation and it is also known that oxidative phosphorylation enzymes are one of the 
elements particularly vulnerable to free radicals (Pieczenik & Neustadt, 2007). 
Therefore, as a precursor of GSH’s synthesis, NAC regenerates the GSH levels, which 
in turn, can neutralize the effects of ROS upon mitochondrial complexes. 
The hypothesis of damage in proteins of the respiratory chain was confirmed since 
the AgNPs of both sizes decreased the activity of succinate dehydrogenase (SDH) 
(Complex II). However, only 75-nm AgNPs caused a significantly decreased 
cytochrome c oxidase (COX) (Complex IV) activity (Figure 3.6). These results suggest 
that, unlike 75 nm-AgNPs, 10 nm-AgNPs do not cause damage to COX. However, SDH 
is apparently a target for both sizes. 
When the protein content was investigated in mitochondria exposed with either 
sizes of AgNPs, a statistically non-significant trend towards increased mitochondrial-
encoded COX subunit I and nuclear-encoded COX subunit IV was revealed (Figure 
3.10). Thus, in light of the results, one possible explanation for this protein content 
increasing can be that mitochondria developed a compensatory response to overcome 
the decreased activity shown by COX. This way the content of COX subunits increases 
to help the functioning of mitochondrial oxidative system. This mechanism of the 
compensatory response has been already reported by Garcı & Gianotti, (2007). A study 
carried out by Teodoro et al, (2008) demonstrated a similar compensatory response, 
when excessive fat accumulation in hepatocytes leads to mitochondrial bioenergetics 
impairment. In the presence of NAC, COX-IV content shows a significant decrease 
when exposed to 75nm-AgNPs. In this condition, COX activity showed a similar value 
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to the control and, therefore, the compensatory response was not needed and the protein 
content did not increase.  
To further explore and understand the cause for the enlarged lag phase, showing 
impairment in phosphorylative system, and a decrease in respiratory state 3, we 
evaluated ATPase activity since this results suggested that AgNPs exposure could affect 
ATPase efficiency. ATPase activity was dramatically decreased in mitochondria 
exposed to both sizes of AgNPs (Fig.3.4). The activity of the mitochondrial ATPase 
revealed that liver mitochondrial bioenergetics, in addition to damage to the oxidative 
system, also have imparments in the phosphorylative system. Thus, mitochondrial 
ATPsynthase is probably one target of toxicity induced by AgNPs. Despite these 
alterations on ATPase activity and unlike the studies reporting ATP depletion (Asharani 
et al., 2009; Hiura et al., 2000), ATP content did not reveal any alterations (Fig 3.5). 
These results suggest that despite the decrease of ATPase activity, mitochondria are still 
able to produce the ATP required for the cell. However, ATP production requires more 
time than in mitochondria that were not exposed to nanoparticles. Thus, despite the 
hepatocellular damages caused by AgNPs shown by the increase in plasmatic AST and 
LDH activities, the oxidative phosphorylation capacity of hepatic mitochondria is able 
to keep the ATP levels when chronically exposed to these low doses of AgNPs. 
ROS generation is a hallmark of mitochondrial dysfunction caused by AgNPs 
exposure. As previously demonstrated, AgNPs induced generation of ROS, depletion of 
antioxidant GSH and reduction of mitochondrial function (Arora et al., 2008; Carlson et 
al., 2008; Hussain et al., 2005). Thus, it is believed that cellular oxidative stress may be 
the main responsible for cytotoxicity of AgNPs (Asharani, Low, et al., 2009; Jing et al., 
2011; Monteiller et al., 2007). Hsin et al., (2008) showed inhibition of ROS production 
induced by AgNPs in cell pretreated with cyanide, an inhibitor of the mitochondrial 
electron-transferring activity of COX. This suggests that mitochondria are involved in 
AgNPs-mediated ROS generation. Our data shows a significant increase on ROS 
generation in mitochondria isolated from animals treated with both AgNPs sizes (Figure 
3.7), suggesting that ROS generation is clearly an effect of AgNPs administration. 
Unlike that was expected, mitochondria isolated from the livers exposed to NAC 
revealed statistically non-significant trend towards decreased ROS production in both 
sizes of AgNPs. One possible explanation can be the fact that as ROS generation is 
maximal in this assay, NAC was inefficient to deal with such high values. However, in 
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physiological conditions, ROS generation induced by AgNPs is lower allowing the 
protective effect of NAC as have been seen throughout the results. 
The calcium retention capacity of isolated mitochondria is a well established 
indicator of function and integrity, since it is linked to the permanent opening of the 
mitochondrial permeability transition (MPT) pore. Therefore, increase in mitochondrial 
permeability is a manifestation of mitochondrial dysfunction and is associated with 
induction of apoptosis and necrosis death (Kroemer et al., 2007; Varela et al., 2008).  
MPT induction disrupts the impermeability barrier of the inner membrane leading to 
membrane potential and pH gradient dissipation that together drive ATP synthesis 
through oxidative phosphorylation, causing impairment of mitochondrial function 
(Teodoro et al., 2011). This induced mitochondrial permeability is associated with 
pathological conditions and is triggered by high Ca
2+
 levels, oxidative stress, ATP 
depletion, high-inorganic phosphate and mitochondrial depolarization (Abou-Sleiman et 
al., 2006). A recent study demonstrated that mitochondria pre-incubated with different 
AgNPs sizes (40- and 80-nm) were more susceptible to mitochondrial swelling when 
compared to control (Teodoro et al., 2011). Our data shows a similar effect in 
mitochondria isolated from animals exposed to 10-nm or 75-nm AgNPs (Figure 3.8). 
The lower calcium buffering capacity of mitochondria exposed to AgNPs relative to the 
control suggest the compromising of mitochondrial integrity by AgNPs. These 
mitochondria are more susceptible to MPT induction, which allows the release of 
cytochrome c and other apoptogenic proteins stored within mitochondria, leading to the 
induction of the apoptotic dismantling of the cell (Rasola & Bernardi, 2011). 
Oxidative stress and abnormally high levels of intramitochondrial Ca
2+
 are probably 
the two most important activators of MPT pore (Toman & Fiskum, 2011). These two 
factors interact synergistically, when mitochondria are oxidatively stressed, much lower 
levels of Ca
2+
 are required to activate MPT pore (Fiskum, 2000). 
NAC supplementation was significantly able to recover the calcium retention 
capacity in both sizes and doses of calcium. Once again, these results suggest that NAC 
decreases the oxidative stress within the cell leading to a higher mitochondrial integrity. 
As can be seen throughout the results, the efficiency of NAC to prevent the effect 
of AgNPs was higher in 75 nm- than 10 nm-AgNPs. ATP synthase and Succinate 
dehydrogenase activity and RCR are one of the examples where the preventive effect of 
NAC was only efficiently in mitochondria exposed to 75nm-AgNPs. Therefore, these 
results suggest that the smaller NPs, 10nm-AgNPs, showed a higher cytotoxicity than 
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larger NPs, 75nm-AgNPs. Our results are in agreement with previous reports that have 
shown higher cytotoxicity associated with smaller nanoparticles (Ahamed et al., 2008; 
Carlson et al., 2008; Monteiller et al., 2007). 
In summary, this work aimed to evaluate the effects that are elicited by AgNPs 
exposure upon hepatic mitochondria. In vivo exposure to AgNPs caused impairment of 
rat liver mitochondrial function, due mainly to alterations of mitochondrial membrane 
permeability. The enhancement of H
+
 leak results in an uncoupling effect on the 
oxidative phosphorylation system. 
AgNPs also compromises the electron transfer along the electron transport chain by 
affecting complex II and IV of the respiratory chain. This impairment of mitochondrial 
electron transport chain activity causes accumulation of electrons in the electron 
transport chain complexes that can escape and directly react with oxygen to form the 
superoxide anion radical (Ribeiro et al., 2014). As oxidative stress is one of the 
mechanisms regulating the MPT pore opening, AgNPs also induced the MPT. 
As previously mentioned, NAC was used in our study to understand whether the 
oxidative stress increase due to AgNPs exposure can be prevented by this antioxidant.  
Overall, we found that most of the effects caused by AgNPs exposure were prevented 
by pretreatment with NAC. This antioxidant agent efficiently prevented the structural 
damage to the inner mitochondrial membrane as evidenced by the recovery of 
mitochondrial membrane potential, and state 4 and vOligomycin respiration. Damage to 
mitochondrial electron transport chain complexes was also prevented by NAC as 
evidenced by the recovery of Complexes II and IV activities. Oxidative phosphorylation 
and calcium retention capacities of hepatic mitochondria were also improved by NAC 
treatment. Thus, NAC seems to be an efficient antioxidant against AgNPs toxicity. The 
prevention of these mitochondrial changes by NAC treatment suggests that ROS are 
involved in the mitochondrial toxicity caused by AgNPs treatment.  
The main toxic effects of AgNPs and the protective mechanism of NAC are 
depicted in Figure 4.1. 
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Figure 4.1- Scheme illustrating the main effects of AgNPs exposure and NAC administration. 
AgNPs can preferentially accumulate in mitochondria. Once within mitochondria, silver nanoparticles can 
interact with mitochondrial GSH, decreasing its levels. The decrease of GSH levels leads to 
mitochondrial oxidative stress increase. ROS generation causes impairment mitochondrial function, due 
mainly to alterations of mitochondrial membrane permeability leading to H
+
 leak. AgNPs also 
compromises the electron transfer along the electron transport chain by affecting respiratory chain 
complexes. As oxidative stress is one of the mechanisms regulating the MPT pore opening, AgNPs also 
induce the MPT. NAC administration increases the levels of mitochondrial GSH, and the consequent 
decreasing of oxidative stress, preventing most of the effects caused by AgNPs exposure. 
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